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Characterization of the RNA binding and RNA
degrading subunits of the eukaryotic exosome
Borislava B. Tsanova, B.S.
Supervisory Professor, Ambro van Hoof, Ph.D.

The exosome is an essential complex of ten proteins involved in the processing
and degradation of many RNAs in the cell. These include various stable RNAs,
mRNAs, and aberrant transcripts both in the nucleus and in the cytoplasm.
In this work I characterize the three members of the exosome “cap”, the RNA
binding proteins Rrp4, Rrp40, and Csl4. I determine that in spite of their structural
similarity, they each have a unique essential role. Second, I determine that two of
the cap proteins Rrp4 and Rrp40 have a role in bridging subunits of the PH ring of
the exosome. The third cap protein Csl4 was shown not to have a bridging role.
Further, I show that stable interaction with the exosome is not required for the
essential role of Csl4.
In addition, I look at the physiological importance of the nuclease domains of the
exosome. I show that the exonuclease is the primary activity for the exosome and
that in its absence the iron starvation response of the cell is activated.
Despite numerous studies of the exosome, only a few address the physiological
relevance of the catalytic activity. This work shows that the exonuclease of the
exosome is important for oxidative stress protection and affects glucose metabolism
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and provides a basis for future research into the physiological importance of this
essential RNase.
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Chapter 1: Introduction, background, and significance
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INTRODUCTION AND BACKGROUND
RNA degradation and processing
RNA degradation is used by all cells for applying temporal control of gene
expression as well as maintaining its fidelity by eliminating aberrant transcripts.
RNAs are degraded either at the end of the RNA life or if they are aberrant. Such
aberrant RNAs may result from genetic mutations, such as nonstop mutations or
mistakes in processing the RNA, such as hypomodification of tRNAs. In each case,
however, the persistence of the aberrant RNA will lead to errors in gene expression,
thus the degradation serves a role as a surveillance mechanism to preserve the
fidelity of gene expression.
The initial transcription of RNAs results in a primary RNA transcript. The primary
RNA transcript is then processed and sometimes edited to produce the final mature
RNA transcript. RNA processing refers to the addition or removal of components of
the RNA. Processing reactions include shortening of the primary RNA transcript
from either the 5’ or the 3’ end and in the case of mRNAs the addition of a 5’ 7methyl guanosine cap, addition of a 3’ poly(A) tail, and RNA splicing to remove
introns (Lodish, 2000).
Often these two processes, RNA degradation and RNA processing are carried out
by the same enzyme. However the recognition of a transcript intended for
degradation from processing is thought to be accomplished by interaction with
accessory proteins. Some proteins associate with the ribonuclease, in which case
they are usually referred to as cofactors, while other proteins associate with the
2

RNA and form complexes called ribonucleoproteins (RNPs). It is believed that the
combination of these factors and their interactions allows the cell to determine the
fate of a particular transcript (Schilders et al., 2006).
Ribonucleases are classified as either endoribonucleases or exoribonucleases.
Endoribonucleases cleave the phosphodiester bond within the RNA polynucleotide
chain, while exoribonucleases cleave phosphodiester bonds at the end of the chain.
The exonucleases can be further subcategorized into either 5’3’ exoribonucleases
or 3’5’ exoribonucleases depending on the end from which they start degrading
the RNA (from the 5’ end or from the 3’ end respectively; Arraiano et al., 2013).
Additionally, ribonucleases may not associate with protein complexes, such as the
5’3’ exoribonuclease Xrn1, or they are assembled into larger protein complexes
such as the major 3’5’ exoribonuclease, the exosome.

The eukaryotic exosome
The major 3’5’ exoribonuclease in eukaryotes and archaea is the exosome
(Chlebowski et al., 2013; Dziembowski et al., 2007). In eukaryotes, the exosome
also has an endonuclease domain (Lebreton et al., 2008; Schaeffer et al., 2009;
Schneider et al., 2009). The eukaryotic exosomes that have been studied so far are
well conserved through evolution (Chlebowski et al., 2013; Decker, 1998). The
exosomes of Saccharomyces cerevisiae and the human exosome are very similar
both in structure and in function (Sloan et al., 2012). They also include homologues
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of the same protein subunits. This similarity makes S. cerevisiae a good model
organism for studying the eukaryotic exosome.

Structure of the exosome
The exosome is a complex of ten proteins, each of which is essential for life.
There are several structures of eukaryotic exosomes including crystal structures of
human and yeast exosomes (Liu et al., 2006; Makino et al., 2013) and EM
reconstitutions of the exosome (Malet et al., 2010; Wang et al., 2007). Additionally,
the catalytic subunit Rrp44 was independently crystallized with RNA and in a
complex with Rrp41 and Rp45 (Bonneau et al., 2009; Lorentzen et al., 2008).
Based on the published structures listed above, nine of the ten proteins assemble
in a cylindrical structure, composed of two rings, and the catalytic subunit is located
on one side of this cylinder (Figure 1-1). The first ring is termed the exosome “cap”
and it is composed of three RNA binding proteins, Rrp4, Rrp40, and Csl4. Each one
of them has an S1 domain which is a known RNA binding domain originally
identified in ribosomal protein S1. These S1 domains form a ring on the side of the
exosome where RNA enters. The cap of the exosome is thought to mediate the
initial interaction with the RNA substrate and/or interact with protein cofactors of the
exosome; therefore it may be important in determining substrate specificity.
The middle portion of the exosome is composed of a larger ring called the PH
ring, because of the RNase PH domains found in each of its component proteins.
However, unlike RNase PH, the eukaryotic PH ring is inactive, lacking catalytic
4

activity. In archaea the PH ring is where catalysis occurs, but the active sites of
eukaryotic exosomes have point mutations rendering them inactive (Dziembowski et
al., 2007; Liu et al., 2006). The PH ring is composed of six proteins, Rrp41, Rrp42,
Rrp43, Rrp45, Rrp46, and Mtr3. The 3’end of the RNA to be degraded is threaded
through the PH ring as it emerges from the cap (the RNA binding ring) into the
catalytic subunit Rrp44.
The tenth subunit, Rrp44, is located on the side where the RNA exits the ring
(Wang et al., 2007). It has an exonuclease domain which faces the RNA exit site of
the exosome and an endonuclease domain which faces away from the PH ring
cylinder (Malet et al., 2010). Rrp44 is the only site of RNA degradation in the
eukaryotic exosome. For detailed review on the structure and function of Rrp44 see
Chapter 5.

The RNA binding proteins of the exosome
Studies of individual eukaryotic RNA binding proteins are limited. For example,
RNA binding affinity has been studied only in Rrp40 and the reports are conflicting
with one study reporting no RNA binding while another showing RNA binding by
Rrp40 (Luz et al., 2007; Oddone et al., 2007). Eukaryotic Csl4 has been studied
specifically for its role in the cytoplasmic mRNA degradation by the exosome and a
point mutation in its Zn ribbon-like domain (see chapter 4) was found to affect
specifically 3’5’ mRNA degradation by the exosome (van Hoof et al., 2000b).

5

Figure 1-1. Structure of the exosome. Depiction of the structure of the 10 subunit
eukaryotic exosome with RNA (in green). Locations of the exonuclease and the
endonuclease within Rrp44 are show with asterisks (*).
6

In archaea, the exosome has two RNA binding proteins, Rrp4 and Csl4 which are
homologous to Rrp4 and Csl4 of S. cerevisiae respectively. Archaeal Rrp4 is
homologous to Rrp40 from eukaryotes, too. Archaea have several forms of the
exosome, which differ by the stoichiometry of their RNA binding proteins while the
PH ring remains the same. Exosomes with three Csl4 proteins, three Rrp4 proteins,
or heterogeneous composition of the cap with mixed Rrp4 and Csl4 stoichiometry
have been described (Buttner et al., 2005; Walter et al., 2006). The reason for this
variability seems to be that, at least in archaea, the RNA binding proteins confer
specificity to the exosome. This specificity is conferred in two ways. First, Rrp4 and
Csl4 provide different substrate specificities to the exosome. Rrp4 exosomes prefer
A-rich substrates while Csl4 exosomes prefer A-poor substrates (Roppelt et al.,
2010). Second, different exosome complexes interact with different cofactors. For
example, DnaG only interacts with a Csl4 exosome, but not with an Rrp4 exosome
(Hou et al., 2013). The binding of DnaG enhances the interaction of a Csl4
exosome with A-rich substrates which are otherwise preferred by the Rrp4
exosome. Even though there is high conservation of the RNA binding proteins it is
unknown if their role in providing substrate specificity and/or protein interactions is
also conserved in higher organisms.

Catalytic activity of the exosome
Exosomes from all organisms have exoribonuclease activity. In archaea, the PH
ring is the site of RNA degradation (Lorentzen et al., 2005). Eukaryotic exosome
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have point mutations in the PH ring subunits, which render them catalytically
inactive (Dziembowski et al., 2007; Liu et al., 2006). However, in eukaryotes there is
a tenth subunit, Rrp44, which provides the catalytic activity of the exosome. More
specifically, Rrp44 has processive hydrolytic 3’5’ exoribonuclease activity instead
of the PH ring catalysis found in the archaeal exosome (Liu et al., 2006).
Additionally, eukaryotes have evolved endoribonuclease activity, which is also
found in Rrp44 but in a separate domain (Lebreton et al., 2008; Schaeffer et al.,
2009; Schneider et al., 2009).
Most eukaryotes have one Rrp44 subunit which harbors both the exonuclease
and the endonuclease domains. Human cells have subfuncitonalized the
ribonucleases of the exosome even further. This subfunctionalization involves both
cellular compartmentalization as well as catalytic activity. There are three
homologues of Rrp44 in humans: hDIS3, hDIS3L, and hDis3L2. hDIS3 is found
predominantly in the nucleus of human cells, while hDIS3L and hDIS3L2 are strictly
cytoplasmic. Only the nucleus- localized hDis3 has endonuclease activity, while the
other two homologues have only exoribonuclease activity (Astuti et al., 2012; Staals
et al., 2010; Tomecki et al., 2010). In Schizosaccharomyces pombe, Dis3L2 does
not associate with the exosome but still takes part in the cytoplasmic mRNA
degradation pathway (Malecki et al., 2013).

8

Role of the exosome in the nucleus
The exosome was first discovered in S. cerevisiae as a nuclear ribosomal RNA
processing machine required for the maturation of the 5.8S rRNA (Mitchell et al.,
1997). Specifically, it was discovered that in the nucleus the complex plays a role in
the maturation of 5.8S rRNA and also of the degradation of the 5’ External
transcribed spacer (ETS) of rRNA (de la Cruz et al., 1998). During the 5.8S rRNA
maturation, the exosome degrades the 7S rRNA down to 5.8S + 30 nucleotides and
then the final processing is dependent on Rrp6 (Allmang et al., 1999a). After the
initial discovery, many studies have added various roles for the exosome making
the exosome one of the most versatile cellular machines affecting most RNAs in the
cell.
In addition to rRNA maturation, the exosome also takes part in the processing of
snoRNAs, and snRNAs (Allmang et al., 1999a; van Hoof et al., 2000a). The 3’ end
of snRNAs U1, U4, and U5 are processed by the exosome. In this role the exosome
functions together with Rrp6 by completing the final 3’ processing steps. The
exosome degrades the initial 3’ nucleotides and then the final nucleotides are
degraded in Rrp6-dependent manner.
snoRNAs can be independently transcribed or intron-derived. The exosome
processes several snoRNAs together with its nuclear cofactor Rrp6, but not all
snoRNAs require the exosome for 3’ maturation. As with the 5.8S rRNA and
snRNAs, Rrp6 is only required for the final steps of snoRNA maturation, specifically
the trimming of the last 3 nucleotides (Allmang et al., 1999a; van Hoof et al.,
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2000a).
In addition to processing, the exosome takes part in surveillance mechanisms,
specifically the degradation of hypomodified tRNAMet , misprocessed rRNAs, cryptic
unstable transcripts (CUTs), and the cotranscriptional surveillance of pre-mRNAs,
(Andrulis et al., 2002; Kadaba et al., 2004; Thiebaut et al., 2006).
The essential role of the exosome is also believed to be in the nucleus. Deletion
of the cytoplasmic cofactors of the exosome, which are required for all known
cytoplasmic roles, is not lethal (Rhee et al., 1989; Sommer and Wickner, 1987; van
Hoof et al., 2000b; Widner and Wickner, 1993). Additionally, some of the nuclear
exosome cofactors are essential, specifically Mtr4 and all three components of the
Nrd1/Nab3/Sen1 complex (Liang et al., 1996; Steinmetz and Brow, 1996; Wilson et
al., 1994). It is not known what specific role of the exosome complex is essential
because many of the nuclear roles of the exosome are potentially essential.
In the cytoplasm, the exosome takes part in the 3’5’ degradation of normal and
aberrant mRNAs (see Normal mRNA degradation by the exosome in the cytoplasm
in this chapter). In addition various exosome roles require different cofactors, thus it
seems that the specificity of the degradation/processing targets is not determined
by the exosome itself.

Nuclear exosome cofactors
In the nucleus the exosome associates with Rrp6, an exonuclease homologous to
RNase D from Escherichia coli. Rrp6 localizes to the nucleus in S. cerevisiae, but in
10

human cells and trypanosomes it has been found to be both in the nucleus and in
the cytoplasm (Brouwer et al., 2001; Haile et al., 2007). In vitro, Rrp6 forms a
complex with the exosome of S. cerevisiae (Makino et al., 2013). Because Rrp6
also interacts with the exosome in vivo, it is inferred that this complex forms in the
cell’s nucleus (Allmang et al., 1999b). While Rrp6 functions together with the
exosome in 5.8S rRNA maturation where it is required for the degradation of the last
30 nucleotides (Briggs et al., 1998), and maturation of snRNAs and snoRNAs
(Allmang et al., 1999a; van Hoof et al., 2000a), it also has exosome independent
roles. For example, it degrades the last three nucleotides of some snoRNAs in an
exosome independent manner (Allmang et al., 1999a; van Hoof et al., 2000a). Rrp6
has also been found to be required independently of the exosome for cell
proliferation and error-free mitosis in Drosophila melanogaster cells (Graham et al.,
2009b)
Additional nuclear cofactors of the exosome include Mtr4 and the TRAMP
complex. Mtr4 is an RNA helicase which functions together with the exosome for its
processing functions, specifically for processing of 5.8S rRNA, snoRNA, and
snRNAs (Allmang et al., 1999a; de la Cruz et al., 1998; van Hoof et al., 2000a). For
the degradation function of the exosome, Mtr4 is assembled in a complex, the
TRAMP complex, with an RNA binding protein and a poly(A) polymerase, either
Air1 or Air2 and either Trf4 or Trf5 respectively (Grzechnik and Kufel, 2008; LaCava
et al., 2005; Rougemaille et al., 2007; Vanacova et al., 2005). Trf4 and Trf5 add
short poly(A) tails to RNAs and these poly(A) tails are thought to promote
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degradation by the exosome and it appears as each of them has different target
RNAs (San Paolo et al., 2009).
Another complex with which the exosome is known to associate in the nucleus is
the Nrd1/Nab3/Sen1 complex. Together with the exosome it functions in the
processing of snRNAs and snoRNAs and degradation of misprocessed mRNAs and
cryptic unstable transcripts (CUTS;Conrad et al., 2000; Thiebaut et al., 2006;
Vasiljeva and Buratowski, 2006). Additionally the Nrd1/Nab3/Sen1 complex was
shown to be involved, together with Rrp6 and the TRAMP complex, in the 3’ end
processing of the CTH2 mRNA, which codes for a protein functioning in iron
response (Ciais et al., 2008). Nrd1 and Nab3 have also been implicated in
regulating the cellular response to nutrient availability (Darby et al., 2012)
As described, the exosome functions in processing or degradation of virtually all
types of RNAs in the nucleus. For its various roles the exosome associates with
many proteins and/or protein complexes. Most of these nuclear cofactors of the
exosome have exosome-independent roles. Additionally, combinations of cofactors
have been identified functioning together for some roles of the exosome. Such
highly complex organization is indicative of the complicated nature of RNA
recognition and degradation in the nucleus, of which the exosome is a major player.
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Role of the exosome in the cytoplasm
In the cytoplasm the exosome plays a role in three general processes. First, it
takes part in one of the two pathways for degradation of normal mRNAs. Second, it
degrades aberrant mRNAs. Third, it has an antiviral role. For a depiction of normal
an aberrant mRNA degradation see Figure 2.

Cytoplasmic cofactors of the exosome
For all of its known cytoplasmic roles the exosome requires Ski7 and the Ski
complex. The Ski complex is composed of Ski2, Ski3, and two copies of Ski8 and
has been proposed to interact with the cap of the exosome through Ski7 (Halbach
et al., 2013). Ski7 is believed to function as a scaffold protein because it was found
to interact with both the exosome and the Ski complex (Araki et al., 2001). A point
mutation in Csl4, csl4G253E (published as ski4-1 ) that disturbs the exosome’s role
in the cytoplasm also does not coimmunoprecipitate with Ski7 nor the Ski complex
suggesting that the interaction with the Ski complex is required for the cytoplasmic
exosome function (van Hoof et al., 2000b).

Normal mRNA degradation by the exosome in the cytoplasm
In S. cerevisiae most mRNAs are deadenylated by the Ccr4-Not complex before
being degraded (Decker and Parker, 1993; Tucker et al., 2002; Tucker et al., 2001).
The deadenylation is a rate limiting step for the normal mRNA degradation. After
13

deadenylation, the mRNA can be degraded either from the 5’ end or from the 3’ end
(Decker and Parker, 1993; Muhlrad et al., 1995). For a depiction of cytoplasmic
mRNA degradation see Figure 1-2. When mRNAs are degraded from the 5’ end,
the 7-methyl cap is removed by the decapping enzyme Dcp1/Dcp2 and then the
mRNA is degraded by Xrn1 (Beelman et al., 1996; Dunckley and Parker, 1999;
Muhlrad et al., 1994; Steiger et al., 2003). From the 3’ end mRNAs are degraded by
the exosome, and the cap is then recycled by Dcs1 (Jacobs Anderson and Parker,
1998; Liu et al., 2002; Wang and Kiledjian, 2001). These pathways function in a
redundant manner because each of them is not essential on its own but blocking
both is synthetic lethal (Jacobs Anderson and Parker, 1998). It is likely however that
during normal cellular processes, both pathways take place simultaneously.
Studies suggest that the 3’5’ pathway, which as stated above is the one in which
the exosome is involved, is predominant in humans (Wang and Kiledjian, 2001),
while the 5’3’ pathway is predominant in S. cerevisiae (Jacobs Anderson and
Parker, 1998).

Aberrant mRNA degradation by the exosome in the cytoplasm
The cytoplasmic exosome has been found to take part in mRNA surveillance for
aberrant mRNAs, specifically mRNAs that lack a poly(A) tail or a stop codon (van
Hoof et al., 2002).
The nonstop mRNA degradation pathway is conserved from yeast to humans and
unlike regular mRNA degradation, it is deadenylation independent (Frischmeyer et
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al., 2002). Because translation is required for nonstop mRNA decay and because
ribosomes have been found to stall at the 3’ end of nonstop mRNAs, it is believed
that the exosome is recruited to the nonstop mRNA after, at least, the first round of
translation (Figure 1-2 B; Ito-Harashima et al., 2007; van Hoof et al., 2002). Ski7,
as well as each of the Ski complex proteins, Ski2, Ski3, and Ski8, were also found
to be required for nonstop mRNA decay (van Hoof et al., 2002). Interestingly, the
exoribonuclease and the endoribonuclease of the exosome were redundant for
degrading nonstop mRNAs (Schaeffer and van Hoof, 2011).
Because there are no stop codons, the 3’ UTR and the poly(A) tail would also be
translated resulting in a poly(lysine) tag for the aberrant protein which in turn would
be targeted for degradation by the 26S proteasome. A genetic screen for
suppressors of nonstop mRNA decay identified several mutations involving the
proteasome, thus supporting this model (Wilson et al., 2007).

Antiviral role of the exosome
The cytoplasmic exosome also has antiviral role. S. cerevisiae commonly contains
an endogenous L-A virus. Additionally, some strains contain M satellite RNA which
codes for a toxin (killer toxin) that is secreted from the cell and kills neighboring cells
that are not infected. The expression of the M satellite is dependent on RNAdependent RNA polymerase which is encoded by the L-A virus (Wickner et al.,
1991). The cytoplasmic exosome is implicated in surveillance of the M satellite
because all of the ski mutants were identified in S. cerevisiae in a screen for
15

Figure 1-2. Cytoplasmic mRNA degradation by the exosome. A. The exosome in the
normal mRNA degradation pathway. This pathway is deadenylation dependent. mRNAs are
first deadenylated by the Ccr4-Not complex and then degraded either 5’3’ by Xrn1 (after
decapping by Dcp2, not shown here) or 3’5’ by the exosome. Ski = ski complex. B.
Degradation of aberrant mRNAs by the exosome as exemplified by a nonstop mRNA.
Deadenylation is not needed and these mRNAs are degraded directly by the exosome
which is facilitated by the ski complex and Ski7.
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increased secretion of the killer toxin (Ridley et al., 1984; Toh et al., 1978). Two of
the proteins, Ski4 and Ski6, later were determined to be the exosome components
Csl4 and Rrp41 respectively (Mitchell et al., 1997; van Hoof et al., 2000b) and
several of these encode cytoplasmic cofactors of the exosome such as Ski7 and the
Ski complex proteins Ski2, Ski3, and Ski8 (Brown et al., 2000). The exact
mechanism of exosome involvement is not known, but it seems that the secretion
of the killer toxin is affected by lowering the viral RNA levels presumably by
degrading it.

SIGNIFICANCE OF THIS STUDY

Exosome-dependent processing and degradation of RNAs affects virtually all
cellular processes
Degradation of RNA is an essential process, important for normal cellular function
at many levels. RNA surveillance, maturation and gene expression control involve
RNA degradation. Therefore, it is of high importance that the processes by which
RNA is degraded are understood. Fundamental understanding of these processes
includes both the basic task of characterizing the proteins that make up the RNA
degrading complexes as well as understanding the global effect these RNase
enzymes have on gene expression.
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This study characterizes the cap proteins of the exosome, which is the major
3’5’ exoribonuclease in eukaryotes and archaea. These three proteins are at the
site of RNA entry and have several RNA binding domains. This study shows that
not only do they have a functional role in the exosome, but they likely also have a
structural role. It adds to our understanding of how the complex is held together and
gives us a possible explanation of why three so similar proteins have unique roles.
Further, this research addresses the global effect of the exonuclease on the cell. It
shows that the ultimate effect on gene expression is not as extensive as would be
expected from the number and variety of substrates of the exosome. Identifying the
major cellular processes that are affected by the exosome is significant because it
adds to our understanding of global exosome regulation as well as opens the way to
new research in the area of functional relevance in addition to the more technical
study of individual substrates.

Importance to translational research
The exosome is important in human related research for four general reasons.
First, mutations of exosome components themselves cause disease in humans.
Specifically related to this study, mutations in Rrp40 cause severe neurological
problems in infants (Wan et al., 2012). For detailed description of Rrp40 mutations
related to health see Chapter 3. In addition, a mutation in two of the cytoplasmic
co-factors of the exosome, Ski2 and Ski3, cause Syndromic diarrhea, a GI disorder
(Fabre et al., 2012). Finally, mutations in one of the human homologues of Rrp44,
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Dis3L2 cause Perlman syndrome which is a genetic disorder characterized by
susceptibility to a childhood associated nephroblastoma (Astuti et al., 2012).
Second, mutations that target the mutated transcript to the exosome, such as
nonstop mutations, cause disease in humans such as hemorrhages, muscular
dystrophy and Diamond-Blackfan anemia (Ameri et al., 2007; Cacciottolo et al.,
2011; Klauer and van Hoof, 2012; Willig et al., 1999). Third, the exosome is a target
of the immune system in the case of the autoimmune disease
polymyocitis/scleroderma (Allmang et al., 1999b). Fourth, the exosome’s activity is
also targeted for cancer treatment by the drug 5FU (Fang et al., 2004; Silverstein et
al., 2011).
The exosome has antiviral role in S. cerevisiae. Because it is such a conserved
and versatile RNase it is also possible that it has antiviral role in human cells.
Therefore a study of the east exosome’s activity will be beneficial for future work in
understanding how cells detect and neutralize infection by RNA viruses.
Understanding how the exosome works, may help develop new therapeutic
options for people that have exosome-related diseases. Moreover, because the
exosome structure and function are so well conserved from yeast to human, S.
cerevisiae is a well-suited model organism for its study. The knowledge gained from
the S. cerevisiae exosome may benefit the research when applied to the human
organism.
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Chapter 2: Materials and methods
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Yeast strains, media and growth conditions
Strains
All yeast strains used in this study are haploid and are listed in Table 2-1.

Media
All of the S. cerevisiae strains used in this work were grown, unless otherwise
specified, in YPD (yeast peptone dextrose) medium composed of 1% yeast extract,
2% peptone, 2% dextrose or in synthetic complete (SC) drop-out powder obtained
from Sunrise Science Products, lacking the specified nutrient for plasmid selection.
YPD medium with 5.74 mM of 5-fluoroorotic acid (5FOA) was used to select for
strains that have lost a plasmid with a URA3 marker for plasmid shuffle assay (see
below).

Growth conditions
Unless otherwise noted all cultures were started overnight in 5 ml YPD and then
transferred the next morning to the specified medium and grown at 30oC.
For assays requiring RNA or protein isolation, cell cultures were grown to
OD600=0.6, centrifuged, the supernatant was removed and the cells were washed
with H2O, collected and frozen at -80oC.
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Table 2-1 Strains used
Strain
name
yAV1104
yAV1107
yAV1047
yAV40
yAV245
yAV229
yAV253
yAV255
yAV1128
yAV340
yAV1117
yAV1129
yAV1131
yAV1284
yAV1135

Genotype

Reference

MATa; leu2-0; lys2-0; ura3-0; his3-1; rrp4::NEO
[RRP4, URA3]
MATa; leu2-0; LYS2; MET15; ura3-0; his3-1;
rrp40::NEO [RRP40, URA3]
MATa; leu2-0; LYS2; met150; ura3; his3-1;
csl4::NEO [CSL4, URA3]
MAT; trp1-; leu2-3; lys2-201; ura3-52; HIS4; CUP1; rrp41; ade1-100
MATa; trp1; LEU2; lys2; ura3-52; HIS4; CUP1; mtr14-1,
ade1; aro-; HIS3; HIS1
MATa; TRP1; leu2-3; LYS2; ura3-52; his4-519; CUP1;
ade1-100; rrp4::GAL10-protA-RRP4
MATa; trp1; leu21; LYS2; ura3-52; HIS4; CUP1;
GAL::rrp40; his3200; gal2; gal108
MATa; trp1; leu2-1; LYS2; ura3; HIS4; CUP1; GAL::csl4;
his3200; gal2; gal108
leu2-0; ura3-0; his3-1; rrp4::HYG; rro40::NEO;
MET15 [RRP4, URA3] [RRP40, URA3]
MATa; trp1; leu2; lys2; ura3; HIS4; CUP1::LEU2PM; dcp12:;TRP1; ski4-1
MATa, his31, leu20, ura30, met150, RRP43myc::HIS3
MAT; leu2-0; ura3-0; his3-1; rrp44::NEO [RRP44,
LEU2]
MAT; leu2-0; ura3-0; his3-1; rrp44::NEO [RRP44
D551N, LEU2]
MATa; TRP1; leu2-; lys2; ura3-; HIS4; CUP1; his3;
rrp44::NAT [RRP44, LEU2]
MAT; leu2-0; ura3-0; his3-1; rrp44::NEO [RRP44
D171A, LEU2]

(Schaeffer et al., 2009)
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(Schaeffer et al., 2009)
(Schaeffer et al., 2009)
This study
T2639 from A. Tartakoff
(Mitchell et al., 1997)
(Mitchell et al., 1997)
(Mitchell et al., 1997)
This study
(van Hoof et al., 2000b)
(Schaeffer et al., 2009)
This study
This study
This study
This study

Oxidative stress media
Oxidative stress was achieved by adding 2.0H2O2 or 50of menadione to
the medium in which the strain were grown. Both liquid and solid media were
supplemented with the same concentrations. For some experiments 1.0H2O2
was used, because rrp44-exo- stopped growing at 2.0H2O2.

Iron supplementation and depletion
When iron was added to medium, it was added as 100FAS (ferrous
ammonium sulfate). To chelate iron, 100of the iron chelator
bathophenanthroline disulfonate (BPS) was added to the medium.

Respiratory growth media
YEP + 2% glycerol or YEP + 2% ethanol media were used to stimulate respiratory
growth conditions.

Yeast transformation
Transformation was done as described (Schiestl and Gietz, 1989). Briefly, yeast
cells were incubated with 1g of plasmid in 300 L of PLATE (40%v/v PEG3350,
0.1M LiAc, 10 mM TrisHcl, 1 mM EDTA) solution and 10L heat denatured ssDNA.
Incubation was done at room temperature overnight. Then the cells were
centrifuged, the PLATE solution removed and the yeast cells were plated on
selective medium.
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Table 2-2. Plasmids used
Name

Description

Marker

Vector
backbone

Insert : origin

pAV188

His3 nonstop reporter

URA3

CEN

(van Hoof et al., 2002)

pAV302

Csl4 3’ UTR

LEU2

CEN

PCR with oAV366 and
oAV118

pRS415

pAV303

Csl4 1-126

LEU2

CEN

pAV302

pAV304

Csl4 1-251

LEU2

CEN

pAV305

Csl4

LEU2

CEN

pAV335

Csl4 111-292

LEU2

CEN

PCR with oAV365 and
oAV372
PCR with oAV365 and
oAV371
PCR with oAV365 and
oAV370
PCR with oAV405 and
oAV370

pAV421

Rrp4 3'UTR in pRS415

LEU2

CEN

pRS415

pAV425

Rrp4 full length

LEU2

CEN

pAV441

Rrp4 1-105

LEU2

CEN

pAV442

Rrp4 1-190

LEU2

CEN

pAV443

Rrp4

URA3

CEN

pAV444

Gal_Csl4 in pRS425

LEU2

2

pAV445

Gal_Rrp4 in pRS425

LEU2

2

pAV446

Gal_Rrp40 in pRS425

LEU2

2

pAV447

Rrp40 1-65

URA3

CEN

pAV448

Rrp40 1-140

URA3

CEN

pAV449

Rrp40

URA3

CEN

pAV459

Rrp40 1-65

LEU2

CEN

pAV460

Rrp40 1-140

LEU2

CEN

PCR with oAV424 &
oAV425
PCR with oAV426 &
oAV429
PCR with oAV426 &
oAV500
PCR with oAV426 and
oAV501
Digest of pAV426 with
XbaI and XhoI
pAV345 digestion with
PvuII
pAV346 digestion with
PvuII
pAV 347 digestion with
PvuII
PCR of Rrp40 ( 1-65)
with oAV 432 and
oAV506
PCR of Rrp40 ( 1-140)
with oAV432 and
oAV507
PCR of Rrp40 ( 1-240)
with oAV 432 and
oAV508
pAV447 digestion with
XbaI and HindIII
pAV448 digestion

pAV461

Rrp40

LEU2

CEN

pAV449 - digestion

pS415

pAV466

Rrp40 65-240

LEU2

CEN

pAV465

pAV467

Rrp40 140-240

LEU2

CEN

pAV469

Rrp40 65-240

URA3

CEN

PCR with oAV531 and
oAV431
PCR with oAV532 and
oAV431
pAV466

pAV470

Rrp40 140 -240

URA3

CEN

pAV467

pRS416

pAV471

Rrp4 105-359

LEU2

CEN

pAV464

pAV472

Rrp4 190 -359

LEU2

CEN

pAV476

TAP tag

LEU2

CEN

pAV477

5' UTR of Rrp 4 + 3'
TAP tag
5' UTR of Rrp 40 + 3'
TAP tag

LEU2

CEN

LEU2

CEN

PCR with oAV528 and
oAV425
PCR with oAV529 and
oAV425
PCR with oAV556 and
oAV557
PCR with oAV556 and
oAV557
PCR with oAV556 and
oAV557

pAV478
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Vector: origin

pAV302

pAV302
pAV305

pAV421
pAV421
pAV421
pRS416
pRS425
pRS425
pRS425
pRS436

pAV436

pAV436

pRS415
pRS415

pAV465
pRS416

pAV464
pRS415
pAV464
pAV464

Table 2-2. Plasmids used (continued)
Name

Description

Marker

pAV487

Rrp4 1-105-TAP

LEU2

Vector
backbone
CEN

Insert : origin

Vector: origin
pAV476

CEN

PCR with oAV533 and
oAV558
PCR with oAV533 and
oAV559
PCR with oAV528 and
oAV560
PCR with oAV529 and
oAV560
PCR with oAV533 and
oAV560
PCR with oAV534 and
oAV561
PCR with oAV534 and
oAV562
PCR with oAV531 and
oAV563
PCR with oAV532 and
oAV563
PCR with oAV534 and
oAV563
Mutagenesis with
oAV595 and oAV596
Mutagenesis with
oAV597 and oAV598
Mutagenesis with
oAV599 and oAV600
Mutagenesis with
oAV601 and oAV602
Digestion of pAV441

pAV488

Rrp4 1-190-TAP

LEU2

CEN

pAV489

Rrp4 105-359-TAP

LEU2

CEN

pAV490

Rrp4 190-359-TAP

LEU2

CEN

pAV491

Rrp4-TAP

LEU2

CEN

pAV492

Rrp40 1-65-TAP

LEU2

CEN

pAV493

Rrp40 1-140-TAP

LEU2

CEN

pAV494

Rrp40 65-240-TAP

LEU2

CEN

pAV495

Rrp40 140-240-TAP

LEU2

CEN

pAV496

Rrp40-TAP

LEU2

CEN

pAV532

Rrp4 S152A

LEU2

CEN

pAV533

Rrp4 S152E

LEU2

CEN

pAV534

Csl4 S94A

LEU2

CEN

pAV535

Csl4 S94E

LEU2

CEN

pAV541

Rrp4 1-105

HIS3

pAV542

Rrp4 1-190

HIS3

CEN

Digestion of pAV442

pRS413

pAV543

Rrp4-TAP

URA3

CEN

pRS416

pAV544

Csl4 W272A

LEU2

CEN

pAV545

LEU2

CEN

LEU2

CEN

LEU2

CEN

LEU2

CEN

LEU2

CEN

pAV554

Csl4Y268A,T270A,W2
72A
Rrp4 1-105 + Rrp40
65-240 Chimera
Rrp4 1-190 + Rrp40
140-240 Chimera
Rrp40 1-65+ Rrp4 105359 Chimera
Rrp40 1-140 + Rrp4
190-359 Chimera
Csl4 - V210A, R211A

LEU2

CEN

pAV555

Csl4 - D214A, R215A

LEU2

CEN

pAV556

Csl4 - D216A, R217A

LEU2

CEN

pAV557

Csl4 - S236A, L237A

LEU2

CEN

pAV558

Csl4 110-292 W272A

LEU2

CEN

pAV559

Csl4 110-292
Y268A,T270A,W272A
Csl4 110-292 V210A,
R211A
Csl4 110-292 D214A,
R215A

LEU2

CEN

LEU2

CEN

LEU2

CEN

Digestion of pAV491
with SacI and XhoI
Mutagenesis with
oAV617 and oAV618
Mutagenesis with
oAV619 and oAV620
PCR from pAV461 with
oAV607 and oAV609
PCR from pAV461 with
oAV608 and oAV609
PCR from pAV426 with
oAV604 and oAV606
PCR from pAV426 with
oAV605 and oAV606
Mutagenesis with
oAV629 and oAV630
Mutagenesis with
oAV631 and oAV632
Mutagenesis with
oAV633 and oAV634
Mutagenesis with
oAV635 and oAV636
Mutagenesis with
oAV617 andoAV618
Mutagenesis with
oAV619 andoAV620
Mutagenesis with
oAV629 and oAV630
Mutagenesis with
oAV631 and oAV632

pAV550
pAV551
pAV552
pAV553

pAV560
pAV561
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pAV476
pAV477
pAV477
pAV476
pAV476
pAV476
pAV478
pAV478
pAV476
pAV426
pAV426
pAV305
pAV305
pRS413

pAV305
pAV305
pAV487
pAV488
pAV492
pAV493
pAV305
pAV305
pAV305
pAV305
pAV 335
pAV335
pAV 335
pAV335

Table 2-2. Plasmids used (continued)
Name

Description

Marker

Insert : origin

Vector: origin

LEU2

Vector
backbone
CEN

pAV562

Csl4 110-292 D216A,
R217A

Mutagenesis with
oAV633 and oAV634

pAV335

pAV563

Csl4 110-292 S236A,
L237A

LEU2

CEN

Mutagenesis with
oAV635 and oAV636

pAV335

pAV569

Csl4 110-250

LEU2

CEN

PCR of pAV305 with
oAV405(SphI) and
oAV371(BamHI)

pAV305

pAV582

Csl4 S1(110-250) TAP

LEU2

CEN

PCR from pAV569 with
oAV365 and oAV669

pAV476

pAV583

Csl4 Zn(248-291) TAP
Csl4-TAP

LEU2

CEN

pAV476

LEU2

CEN

HIS3

CEN

HIS3

CEN

Digestion of pAV553

pRS413

HIS3

CEN

Digestion of pAV565

pRS413

pAV643

Rrp40 1-65+ Rrp4 105359
Rrp40 1-140 + Rrp4
190-359 Chimera
Rrp40 (1-65)+Rrp4
(105-190) + Rrp40
(140-240) Chimera
Rrp40

PCR from pAV336 with
oAV365 and oAV661
PCR from pAV305 with
oAV365 and oAV661
Digestion of pAV552

HIS3

CEN

Digestion of pAV461

pRS413

pAV646

Csl4 1-126-TAP

LEU2

CEN

pAV476

pAV647

Csl4 1-250-TAP

LEU2

CEN

pAV648

Csl4 111-292-TAP

LEU2

CEN

pAV649

Csl4 111-292 D251A,
L252A
Csl4 111-292 G253A

LEU2

CEN

LEU2

CEN

pAV651

Csl4 111-292
V254A,V255A

LEU2

CEN

PCR from pAV305 with
oAV365 and oAV699
PCR from pAV305 with
oAV365 and oAV668
PCR from pAV305 with
oAV365 and oAV61
Mutagenesis with
oAV700 and oAV701
Mutagenesis with
oAV702 and oAV703
Mutagenesis with
oAV704 and oAV705

pAV652

Csl4 111-292 M267A

LEU2

CEN

pAV335

pAV653

LEU2

CEN

LEU2

CEN

pAV655

Csl4 111-292 M275A,
P278A
Csl4 111-292 E284A,
R286A, K287A
Csl4 111-292 K290A

LEU2

CEN

pAV666

Csl4 1-126-FLAG

LEU2

CEN

Mutagenesis with
oAV706 and oAV707
Mutagenesis with
oAV708 and oAV709
Mutagenesis with
oAV710 and oAV711
Mutagenesis with
oAV712 and oAV713
PCR of pAV303 with
oAV365(XbaI) and
oAV723(BamHI)

pAV667

Csl4 1-251-FLAG

LEU2

CEN

pAV302

pAV668

Csl4 111-292-FLAG

LEU2

CEN

pAV669

Csl4 247-292-FLAG

LEU2

CEN

pAV670

Csl4-FLAG

LEU2

CEN

pAV679

Csl4 1-126 S94E

LEU2

CEN

PCR of pAV304 with
oAV365(XbaI) and
oAV724(BamHI)
PCR of pAV335 with
oAV365(XbaI) and
oAV725(BamHI)
PCR of pAV336 with
oAV365(XbaI) and
oAV725(BamHI)
PCR of pAV305 with
oAV365(XbaI) and
oAV725(BamHI)
Mutagenesis of pAV666
with oAV601 and
oAV602

pAV584
pAV640
pAV641
pAV642

pAV650

pAV654
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pAV476
pR413

pAV476
pAV476
pAV335
pAV335
pAV335

pAV335
pAV335
pAV335
pAV302

pAV302

pAV302

pAV302

pAV666

Table 2-2. Plasmids used (continued)
pAV680

Csl4 111-292-TAP
V210A,R211A

LEU2

CEN

Mutagenesis of pAV648
with oAV629 and
oAV630
Mutagenesis of pAV648
with oAV631 and
oAV632
Mutagenesis of pAV648
with oAV633 and
oAV634
Mutagenesis of pAV648
with oAV635 and
oAV636
Mutagenesis of pAV648
with oAV700 and
oAV701
Mutagenesis of pAV648
with oAV702 and
oAV703
Mutagenesis of pAV648
with oAV704 and
oAV705
Mutagenesis of pAV648
with oAV706 and
oAV707
Mutagenesis of pAV648
with oAV619 and
oAV620
Mutagenesis of pAV648
with oAV657 and
oAV658
Mutagenesis of pAV648
with oAV659 and
oAV660
Mutagenesis of pAV648
with oAV617 and
oAV618
Mutagenesis of pAV648
with oAV708 and
oAV709
Mutagenesis of pAV648
with oAV710 and
oAV711
Mutagenesis of pAV648
with oAV712 and
oAV713
(Marx and Lidstrom, 2001)

pAV648

pAV681

Csl4 111-292-TAP
D214A, R215A

LEU2

CEN

pAV682

Csl4 111-292_TAP
D216A, R217A

LEU2

CEN

pAV683

Csl4 111-292-TAP
S236A, L237A

LEU2

CEN

pAV684

Csl4 111-292-TAP
D251A, L252A

LEU2

CEN

pAV685

Csl4 111-292-TAP
G253A

LEU2

CEN

pAV686

Csl4 111-292-TAP
V254A, V255A

LEU2

CEN

pAV687

Csl4 111-292-TAP
M267A

LEU2

CEN

pAV688

Csl4 111-292-TAP
Y268A,T270A,W272A

LEU2

CEN

pAV689

Csl4 111-292-TAP
Y268A

LEU2

CEN

pAV690

Csl4 111-292-TAP
T270A

LEU2

CEN

pAV691

Csl4 111-292-TAP
W272A

LEU2

CEN

pAV692

Csl4 111-292-TAP
M275A, P278A

LEU2

CEN

pAV693

Csl4 111-292-TAP
E284A, R286A, K287A

LEU2

CEN

pAV694

Csl4 111-292-TAP
K290A

LEU2

CEN

pAV786

cyc1_LacZ

URA3

2

pAV804

cyc1_aft1BS_LacZ

URA3

2

pAV786

2

Oligonucleotides cloning
with oAV886 and oAV88
(Crisp et al., 2003)

pAV843

Aft1-GFP

URA3

pRS413

empty vector

HIS3

CEN

(Mumberg et al., 1995)

pRS415

empty vector

LEU2

CEN

pRS416

empty vector

URA3

CEN

pRS425

empty vector

LEU2

2
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pAV648

pAV648

pAV648

pAV648

pAV648

pAV648

pAV648

pAV648

pAV648

pAV648

pAV648

pAV648

pAV648

pAV648

Plasmids used in this study
Plasmids used in this study are listed in Table 2-2. All plasmids, unless otherwise
noted, have an endogenous promoter and 3’ UTR to ensure expression at normal
endogenous level. Additionally each plasmid has a marker for selection. The
markers used in this work were URA3, LEU2, or HIS3.

C-terminal TAP tag cloning
All of the proteins that were tagged with a TAP tag were tagged at their Cterminus by removing the stop codon of the sequence to be tagged and adding a G
followed by a PstI site (G CTGCAG). That positions the TAP tag in frame and
results in adding 2 alanine residues and a glycine residue between the tagged
protein and the TAP tag. For a depiction of the TAP-tagging see Figure 2.1.

Site-directed mutagenesis
Site directed mutagenesis was performed using Quick Change Protocol
(Stratagene) with the indicated PCR primers and PfuUltra DNA polymerase
(Stratagene). PCR settings were as suggested by the manufacturer as follows:
initial denaturation - 95oC for 30 seconds; 18 cycles of: 95oC for 30 seconds, 55oC
for 1 minute, 68oC – for 1 min per kb of plasmid; one addition cycle of 68oC for 1
min per kB of plasmid length. The PCR was then treated with 1l DpnI (NEB) for 1
hour at 37oC. 2 l of the DpnI treated reaction were transformed in chemically
competent E. coli cells, plated on LB+0.5 mg/ml Ampicillin, and grown at 37oC
overnight. Colonies were then picked, grown on LB + Amp and screened by
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restriction digestion (each primer has a restriction site that does not change the
protein coding sequence for screening) and then the sequence was confirmed by
DNA sequencing.

Growth assays
Liquid growth assays were started with yeast cells at OD600=0.1 from an overnight
culture in YPD, or required selective medium, at 30oC.
Plate growth assays were done as follows. 5x serial dilutions, starting with
OD600=0.6 were done in a 96-well plate and then were spotted on selective plates
and grown at the indicated temperature. Unless otherwise indicated, all pictures
were taken either on day 3 or on day 4 after plating.

Plasmid shuffle assay
The purpose of this assay is to replace an essential protein with a mutant version
of the same protein. A haploid yeast strain with a knock out of the particular gene in
the genome and a plasmid encoded wild-type version with a URA3 marker was
transformed with a mutant gene on a plasmid with the LEU2 marker. Transformants
were selected on SC-Leu-Ura medium, and then growth assays, as described, were
performed on 5FOA. 5FOA selects for cells that have lost the URA3 marker
effectively shuffling the LEU2 vector for the URA3 vector (Boeke et al., 1984).
Growth on 5FOA indicates that the LEU2 born mutant can substitute for the
essential role of the wild-type gene.

29

Table 2-3. Primers used
Name

Sequence

oAV365

CGCGATCTAGAGGAATTCGAATATGATAGACATCC

oAV366

GGTATCGATAAGCTTCGGTGGTATTGTAGG

oAV370

CGCGAGGATCCTTAAAAAGGTTTGGCACATTTGCGCTT

oAV371

CGCGAGGATCCTTAGTCATTCCTTGCAGTGGTCAAA

oAV372

CGCGAGGATCCTTAATTAGCATATTTGTTGGTTTTACGAC

oAV405

CGCTGGCATGCCTTCCTGGGACAGAAAAGGGTCGTAAAACC

oAV424

CGCGAGGATCCCAAAAGCCGCTGTTTACACATTTATAAAC

oAV425

CGCGACTCGAGCTGCTACCTTTGCCAGTGGTAAACC

oAV426

CGCGATCTAGAGGAATACTGGCAGTGCGATTTTCATGC

oAV429

CGCGAGGATCCTATTAGTTGCCGTTACCTCTCA

oAV430

CGCGAGGATCCATGGTATAATTAAAATATATAAACACATAGAT

oAV431

CGCGAAGCTTCGTATTAGATATGTGCACTATAGTTGTCG

oAV432

CGCGATCTAGAGCGTTATACTGCGTTATACTGCG

oAV500

CGCGAGGATCCTATTAGGCATAACGACCTTTCAATGGAATTACCG

oAV501

CGCGAGGATCCTATTACTTTAGAGACCTTGTATGTAAAGAGGC

oAV506

CGCGAGGATCCTAGTTTAAATGTATCTCTTACTAGAATAGTCT

oAV507

CGCGAGGATCCTAGTTTAAGTTGAGTCAAAACATTCTATTTCGGC

oAV508

CGCGAGGATCCTAGTTTACTCCTCCTTGACCGTAAGTAT

oAV527

CGCGATCTAGACGCTTGTGTGACTACGCAAAGATTTAG

oAV528

CGCGATCTAGAAACAGATATGGCCCCAGAAACTGGTGATCACGTCGTAGGG

oAV529

CGCGATCTAGAAACAGATATGAAGTACGGGAAGTTAAGAAACGGG

oAV530

CGCGATCTAGACTCTTGGTTAGTCGAAATGCTGG

oAV531

CGCGATCTAGACATACAAGATGATTCCATCTGTAAACGATTTTGTAATCG

oAV532

CGCGATCTAGACATACAAGATGACTACAGGACGCGATGCTGGTTTCGG

oAV533

CGCGAGAGCTCGGAATACTGGCAGTGCGATTTT

oAV534

CGCGAGAGCTCGCGTTATACTGCGTTATACTG

oAV556

CGCCTGCAGGTCGACGGATCCCCGGGTTAATTAATCCA

oAV557

CGCAAGCTTTGCCGGTAGAGGTGTGGTCAATAAGAGCGAC

oAV558

CGCCTGCAGCGGCATAACGACCTTTCAATGGAATTACCGATAGCA

oAV559

CGCCTGCAGCCTTTAGAGACCTTGTATGTAAAGAGGCACT

oAV560

CGCCTGCAGCGTTGCCGTTACCTCTCATTTTTTCGGCGGT

oAV561

CGCCTGCAGCAATGTATCTCTTACTAGAATAGTCTATATA

oAV562

CGCCTGCAGCAGTTGAGTCAAAACATTCTATTTCGGCTTC

oAV563

CGCCTGCAGCCTCCTCCTTGACCGTAAGTATTTCTTTAAA

oAV595

CCGGGTGGAATTCTAAGAAGAAAAGCTGAAAGTG

oAV596

CACTTTCCTCTTTTCTTCTTAGAATTCCACCCGG

oAV597

CCGGGTGGAATTCTAAGAAGAAAAGAGGAAAGTG

oAV598

CACTTTCAGCTTTTCTTCTTAGAATTCCACCCGG

oAV599

GGAAGAAAAATCAGTCGACGCAGCACCTAATGATGTCACAAG
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Table 2-3. Primers used (continued)
Name

Sequence

oAV600

CTTGTGACATCATTAGGTGCTGCGTCGACTGATTTTTCTTCC

oAV601

GGAAGAAAAATCAGTCGACGCAGAACCTAATGATGTCACAAG

oAV602

CTTGTGACATCATTAGGTTCTGCGTCGACTGATTTTTCTTCC

oAV604

CGCGACTGCAGCTGCCCCAGAAACTGGTGATCACGTCGTAGG

oAV605

CGCGACTGCAGCTAAGTACGGGAAGTTAAGAAACGGGATG

oAV606

CGCGACTCGAGCTGCTACCTTTGCCAGTGGTAAACC

oAV607

CGCGACTGCAGCTATTCCATCTGTAAACGATTTTGTAATCGG

oAV608

CGCGACTGCAGCTACTACAGGACGCGATGCTGGTTTCGG

oAV609

CGCGCTCGAGCGTATTAGATATGTGCACTATAGTTGTCG

oAV612

CGCGAGGGCCCGCCACCATGTCCGAAGTTATCACAATTACCAAGCGG

oAV613

CGCGAGGGCCCGCCACCATGTCTACGTTCATATTCCCTGGTGATAGC

oAV614

CGCGAGGGCCCGCCACCATGGCATGCAATTTTCAGTTTCCAGAAATAGC

oAV617

GGTGGATTAATGTATGCTACAGACGCGCAAATGATGACTTCACCG

oAV618

CGGTGAAGTCATCATTTGCGCGTCTGTAGCATACATTAATCCACC

oAV619

GGTGGATTAATGGCTGCTGCAGACGCGCAAATGATGACTTCACCG

oAV620

CGGTGAAGTCATCATTTGCGCGTCTGCAGCAGCCATTAATCCACC

oAV621

CGCGACTCGAGGCCACCATGTCTACGTTCATATTCCCTGGTGATAGC

oAV629

GGTATAATCCGATCGCAGGATGCAGCGTCTACAGACAGAGAT

oAV630

ATCTCTGTCTGTAGACGCTGCATCCTGCGATCGGATTATACC

oAV631

GGTCTCAGGATGTACGGTCTACAGCCGCCGATCGTGTGAAAGTG

oAV632

CACTTTCACACGATCGGCGGCTGTAGACCGTACATCCTGAGACC

oAV633

GGATGTACGGTCTACCGATCGAGCTGCTGTGAAAGTGATAGAATG

oAV634

CATTCTATCACTTTCACAGCAGCTCGATCGGTAGACCGTACATCC

oAV635

GGGCGCAAGTTTTAGCAGCCGGCGACGGA ACCAACTACTATTTG

oAV636

CAAATAGTAGTTGGTTCCGTCGCCGGCTGCTAAAACTTGCGCCC

oAV653

CGGGAGATATTGTTCGAGCTCAAGTTTTAGCATTAGGTGACGG

oAV654

CCGTCACCTAATGCTAAAACTTGAGCTCGAACAATATCTCCCG

oAV655

CGGGAGATATTGTTCGAGCTCAAGTTTTATCAGCAGGTGACGG

oAV656

CCGTCACCTGCTGATAAAACTTGAGCTCGAACAATATCTCCCG

oAV657

GGTGGATTGATGGCTGCTACAGACTGGCAAATGATGACTAGTCCG

oAV658

CGGACTAGTCATCATTTGCCAGTCTGTAGCAGCCATCAATCCACC

oAV659

GGTGGATTGATGTATGCTGCAGACTGGCAAATGATGACTTCACCG

oAV660

CGGTGAAGTCATCATTTGCCAGTCTGCAGCATACATCAATCCACC

oAV661

CGCCTGCAGCAAAAGGTTTGGCACATTTGCGCTTTTCTGTAGCGCC

oAV668

CGCTCTAGAATGCTTCCTGGGACAGAAAAGGGTCGTAAAACCAACAAATATGCTAAT

oAV669

CGCTGCAGCATTCCTTGCAGTGGTCAAATAGTAGTTGGTTCCGTCACC

oAV670

CGCTCTAGAATGGACCTTGGGGTCGTGTTCGCCAGAGCTGCTAATGGTGCTGGTGG

oAV699

CGCCTGCAGC ATTATTAGCATATTTGTTGGTTTTACGACCC

oAV700

CCACTGCAAGGAATGCCGCTGGGGTCGTGTTCGCCCGAGCTGCT

oAV701

AGCAGCTCGGGCGAACACGACCCCAGCGGCATTCCTTGCAGTGG

31

Table 2-3. Primers used (continued)
Name

Sequence

oAV702

GGAATGACCTTGCGGTCGTGTTCGCCCGAGCTGCT

oAV703

AGCAGCTCGGGCGAACACGACCGCAAGGTCATTCC

oAV704

GGAATGACCTTGGGGCCGCGTTCGCCCGAGCTGCT

oAV705

AGCAGCTCGGGCGAACGCGGCCCCAAGGTCATTCC

oAV706

GGTGCCGGCGGATTGGCGTATGCTACAGACTGGC

oAV707

GCCAGTCTGTAGCATACGCCAATCCGCCGGCACC

oAV708

GCTACAGACTGGCAAATGGCGACTTCTGCAGTTACAGGCGC

oAV709

GCGCCTGTAACTGCAGAAGTCGCCATTTGCCAGTCTGTAGC

oAV710

CCGGTTACAGGCGCTACAGCCAAGGCGGCATGTGCCAAACC

oAV711

GGTTTGGCACATGCCGCCTTGGCTGTAGCGCCTGTAACCGG

oAV712

CGCTACAGAAAAGCGCAAATGTGCCGCACCTTTTTAAGGATCC

oAV713

GGATCCTTAAAAAGGTGCGGCACATTTGCGCTTTTCTGTAGCG

oAV723

GCGGGATCCTCATTTGTCATCGTCGTCCTTGTAGTCATTATTAGCATATTTGTTGGTTTTACGACCC

oAV724
oAV725

GCGGGATCCTCATTTGTCATCGTCGTCCTTGTAGTCATTCCTTGCAGTGGTCAAATAGTAGTTGGTTCCG
TCACC
GCGGGATCCTCATTTGTCATCGTCGTCCTTGTAGTCAAAAGGTTTGGCACATTTGCGCTTTTCTGTAGC

oAV746

CGCTACAGAAAAGCGCAAATGTGCCGCACCTTTTGCTGCAGG

oAV747

CCTGCAGCAAAAGGTGCGGCACATTTGCGCTTTTCTGTAGCG

oAV748

CGC GCTGCAGGT TCTACGTTCATATTCCCTGGTGATAGCTTTCCTGTAG

oAV751

CCAGAAATAGCTTATCCAGGTAAGCTTGCATGCCCACAGTACGG

oAV752

CCGTACTGTGGGCATGCAAGCTTACCTGGATAAGCTATTTCTGG

oAV753

GTAAAAAATATTGCGGTTGCAGTGCTTCCTGGTACCGAAAAGGGT

oAV754

ACCCTTTTCGGTACCAGGAAGCACTGCAACCGCAATATTTTTTAC

oAV886

GATCTCTTCAAAAGTGCACCCATTTGCAGGTGCTCC

oAV887

TCGAGGAGCACCTGCAAATGGGTGCACTTTTGAAGA
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Figure 2.1 Depiction of the TAP tag cloning. Protein sequence, either full-length or
truncated, was fused at the C-terminus with the TAP tag in the manner depicted above in
order to place both sequences in frame. The blue line depicts the nucleotide sequence and
the resulting amino acid sequence between the TAP tag and the protein of interest is
depicted on the bottom in red.
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Cytoplasmic mRNA degradation assay
Cytoplasmic mRNA degradation assays were performed essentially as described
(van Hoof et al., 2000b). Briefly, to test if a protein is involved in the 35’
cytoplasmic mRNA degradation pathway, a strain deleted for the particular protein
was supplemented with a plasmid encoding that same protein or a mutant. The
strain also had a dcp1-2 temperature-sensitive allele of DCP1. Transformants were
grown on selective medium at room temperature. Next, growth assays were
performed, as described above, at room temperature, 30oC and 37oC. Since the
dcp1-2 allele is temperature-sensitive, at non-permissive temperature this strain
does not have a functional 5’3’ decay pathway and can only survive if the 3’5’
pathway is functional. The functionality of the 3’5’ would be provided for by the
plasmid-encoded protein.

Nonstop mRNA degradation assay
This assay was completed as described (van Hoof et al., 2002). Briefly, a strain
with a deletion of one gene on the chromosome, complemented with a mutant allele
of that gene on a plasmid, was transformed with a vector carrying a mutant his3
gene which lacks a stop codon, his3-nonstop. After selecting for transformants,
growth assays were performed as described above, on SC-His medium. Strains that
are proficient in nonstop mRNA degradation rapidly degrade the his3-nonstop
mRNA which leads to failure to grow on SC-His medium. Strains that are deficient in
nonstop mRNA degradation do not recognize the his3-nonstop as aberrant mRNA
and do not degrade it, which allows for the production of histidine and the strain
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grows. The positive control used for this assay was a ski7 strain because ski7
does not have nonstop mRNA decay.

Protein isolation
Total protein was isolated form S. cerevisiae using the alkaline lysis method.
Briefly, cells were grown to OD600 = 0.8 and 4 OD units of cells were removed,
centrifuged, the supernatant was removed and the cell pellet was suspended in 150
ml of lysis solution (1.85 M NaOH with 1% -mercaptoethanol) and incubated on ice
for 10 minutes. 75 ml TCA were added to precipitate the protein and the precipitated
protein was pelleted using centrifugation. The protein pellet was then washed with 1
ml acetone, resuspended in 100 ml of 2x loading buffer and heated at 65oC for 10
minutes to dissolve. 10 l of sample was used for the Western blotting.

Western blotting
Proteins were resolved on 10% SDS-polyacrylamide gel and transferred onto
nitrocellulose membrane using electrophoresis (Towbin et al., 1979). The
membrane was blocked in 5% milk in TBST (Tris-Buffered Saline with 1ml/L
Tween® 20), and then treated with primary antibody for 1 hour, washed three times
in TBST, treated with secondary antibody HRP conjugated for 1 hour, washed again
three times in TBST, and the proteins were detected using ECL Plus Western
Blotting Detection Reagents (GE Healthcare) per manufacturer’s protocol.
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Co-immunoprecipitation (Co-IPs)
Co-IPs were completed as described (Schaeffer et al., 2012). Briefly, cells were
grown to OD600 0.8, centrifuged, and the cells were collected and washed with
ddH2O. The cell pellet was resuspended in 200 l of cold IP50 buffer (50 mM TRISHCl pH7.5, 50 mM NaCl, 2 mM MgCl2, 0.1% Triton) + 0.5M EDTA, 1 M mercaptoethanol, 0.1 mM PMSF, and 1 “Mini-complete protease inhibitor tablet
EDTA free”( Roche) per 10 ml of buffer. The above sample was vortexed with glass
beads for 7 min at 4oC, centrifuged, the supernatant was collected and total protein
was quantified in spectrophotometer using Biorad protein assay Dye reagent. 40 mg
of total protein was used for the Western blotting.

RNA isolation
RNA was isolated by the “Hot phenol” method essentially as described (He et al.,
2008). Briefly, cells were grown to OD600=0.6 and collected by centrifugation and
removal of the supernatant. 500 l of RNA buffer A (0.5 M NaoAc, 0.01M EDTA,
1% DEPC 1% SDS) was added to the cell pellet followed by 500l of RNA
Phenol/BufferA 1:1 ratio, heated to 65oC. The mixture was heated to 65oC for 4
minutes, centrifuged, upper aqueous layer mixed with 500 l of RNA/BufferA was
heated to 65oC again for 4 min. and the previous step repeated. Next, the upper
aqueous layer was mixed with 500l of Buffer A +TE/Chloroform at room
temperature (Phenol: Chloroform is 1:1 ratio) then centrifuged and upper layer
precipitated by the addition of 1 ml of 100% cold ethanol and incubating at -80oC for
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at least one hour. Ethanol was removed and replaced with 70% ethanol and then
the 70% ehtanol was replaced with DEPC treated water. RNA pellet was
resuspended by 5 freeze/thaw cycles and absorbance was measure at 260nm.

RNA gel electrophoresis
Polyacrylamide gels (11.25 ml of 40% 19:1 acrylamide:bisacrylamide, 7.5 ml of
10x TBE, 30 ml of DEPC treated H2O, 34.5g urea, 100l TEMED, 100l 40% APS)
were run to detect RNA fragments smaller that 500nts such as 5.8S rRNA. 5’ ETS,
U4, tRNAs, etc. as indicated in the text. The electrophoresis was run in TBE buffer.
After resolving the RNA by size, it was transferred onto a nylon membrane using
electroblotting in 0.5x TBE buffer for a total 180 volt hours and then the membrane
was subjected to UV crosslinking.
1.3% agarose gels (72 ml ddH2O, 18 ml formaldehyde, 1.3% agarose, 5L 10
mg/ml ethidium bromide 10 ml 10x MOPS buffer,) were run for detection of iron
response mRNAs FIT3 and TIS11. MOPS buffer is 41.8 g MOPS (3-(Nmorpholino)propanesulfonic acid), 16.6 ml NaAc, 20 ml 0.5 M EDTA in 1L H2O, pH
7.0. Agarose gels were run in 1x MOPS buffer and transferred overnight via
capillary action onto nylon membranes and then the membrane was subjected to
UV crosslinking.
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Northern blotting
The sequences of all oligos used as probes for northern blotting are listed in Table
2.3. All probes were 32P 5’ -phosphate - labeled.
Northern blot analysis was performed as described (Meaux and Van Hoof, 2006).
Briefly, nylon membranes onto which RNA was transferred, either from
polyacrylamide or from agarose gels (see above), were washed with prewash buffer
(0.1x SSC, 0.1% SDS) at 65oC for 1 hr, then prehybridized in prehybridization buffer
(10x Denhardt’s solution, 6x SSC, 0.1% SDS) at 42oC for 1 hr and probed
overnight in the same buffer with added radioactively labeled probe at 42oC.
Membranes were washed in wash buffer (6xSSC,0.1% SDS) 3 times (for 5 min, 5
min, and 20 min) and signals were detected by exposing phosphor screens for
empirically determined amount of time and visualized using a STORM840
PhosphorImager (Amersham). A probe for the RNA component of the Signal
Recognition Particle was used as a loading control for both agarose and
polyacrylamide gels.

-galactosidase assay
-galactosidase assays were completed per manufacturer’s instructions
(Promega). Briefly, cells were grown to OD600=0.6. 50 l of cell culture was mixed
with 50 l of Beta-Glo reagent (Promega). The mixture was incubated for 30 min. at
room temperature in 96-well plates and light output and OD600 were measured using
Biotech Synergy MX plate reader. Light output was normalized to OD for each well.
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ROS detection assay
ROS detection assays were completed after optimization as suggested by the
manufacturer (Life technologies). Overnight cultures were diluted to OD600=0.2, then
after growing for 1.5 hr were either treated with H2O2 (for the cells that were
oxidatively stressed) or left untreated. After 1hr treatment 1 ml of culture was
centrifuged and the medium was removed. The cells were washed in phosphate
buffered saline (PBS), resuspended in 1 ml PBS and 252',7'dichlorodihydrofluorescein diacetate (H2DCFDA) was added. Fluorescence was
detected at 525 nm with excitation at 495 nm and Relative Light Units were
normalized to OD in each sample and then all samples were normalized to wildtype.

Glucose utilization assay
To measure percentage of glucose in the medium, cells were grown in liquid YPD
culture as described for 24 hr. OD600 was measured every two hours and at the
same time 1 ml of culture was removed and frozen for analysis. Glucose was
measured using Glucose (HK) Assay Kit (Sigma) used per manufacturer’s
instructions.
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Ethanol output assay
Ethanol was measured using EnzyChomTM Ethanol Assay Kit (BioAssay
Systems) per manufacturer’s instructions.
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Table 2-4. Oligonucleotides used for Northern blotting
Name

Target

Sequence

oAV224

SRP

GTCTAGCCGCGAGGAAGG

oAV777

5.8S rRNA

TTTGCGTGCGTTCTTCATC

oRP756

U4

oAV872

TIS11

GGGAGTTTCCTGCACTTGGC

oAV873

FIT2

CGACGGCTTGAGTGACGGTC

oAV973

Rnase P

GTTCGCCACTAATGACGTCC

oAV976

precursor to tRNA ArgAsp

AGAAACAAAGCACTCACGAT

oAV978

tRNA Glu

CCGAAGCGGGGAGTCGAACCC

oAV979

tRNA Asp

CCGCGACGGGGAATTGAACCC

oAV981

CAF20

CGTCGTCTTCGTCTTCACTTTCC

oAV982

REV1

CTTTCCCACGTTTGGAAGCC

oAV983

YMR304C-A

GCTTTTAGGTAATGCCGC

oAV1025

ATM1

GCCCGAAGACCCAACTATTGCGG

oAV1137

CYB2

CGGTAGAACCGTACGCGCGG

oAV1138

CYT1

GCTGGGGCGTGCAATCCGTG

oAV1141

RIP1

CCTGTACGTGGATTTGCTAGCCAGC

oAV1142

COR1

GCCAAAGACCTCTTGAACTGG

oAV1151

5' ETS

CGAACGACAAGCCTACTG
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Chapter 3: Characterization of Rrp4 and Rrp40 RNA binding proteins of the
exosome
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INTRODUCTION
Currently, it is unknown how the exosome recognizes substrate RNAs.
Recognition is likely to occur at the site of RNA entry where the three cap proteins
of the exosome are located. Because of their location and because each of the cap
proteins contains a known nucleic acid binding domain, S1, the cap proteins are
likely candidates to bind RNA and/or exosome cofactors. Therefore, they may be
important for providing specificity to the exosome.
Mutations in the human ortholog of Rrp40, hRrp40, have been associated with
various human diseases, suggesting the importance of this particular protein to
human physiology, particularly in neurological conditions. For example, mutations
in hRrp40 V80F and D132A are associated with early onset spasticity, distal
amyotrophy, and cerebellar atrophy (Zanni et al., 2013). Additionally, mutations
G31A, A139P, D132A, and W238A have been associated with Pontocerebellar
hypoplasia type 1 (Biancheri et al., 2013; Rudnik-Schoneborn et al., 2013;
Schwabova et al., 2013; Wan et al., 2012). Therefore. characterizing the cap
proteins of the exosome is important for understanding basic cellular RNA
metabolism, but also may have implications for the improvement of human health.
Two of the cap proteins, Rrp4 and Rrp40 share almost identical domain
organization. Each has an N-terminal RPL27-like domain connected to the middle
S1 domain by a linking sequence, and a KH (K homology) domain (Figure 3-1).
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The N-terminal domains of Rrp4 and Rrp40 are similar to a domain found in
ribosomal protein Rpl27, which is involved in protein-protein interactions, thus they
are referred to from now on as RPL27-like domains. Other than this similarity,
nothing much is known about these domains. With regards to their interactions with
the PH ring of the exosome, the RPL27-like domain of Rrp4 interacts with Rrp41,
while the RPL27-like domain of Rrp40 interacts with Rrp46 (Liu et al., 2006).
The S1 domains are well known RNA binding domains, first identified in the
ribosomal protein S1 (Subramanian et al., 1981). These domains are found in many
RNA binding proteins and are highly conserved from prokaryotes to eukaryotes. All
three major exoribonucleases of E. coli, RNase II, RNase R, and PNPase, contain
S1 domains. In eukaryotes, in addition to all three cap proteins of the exosome, S1
domains are found in the initiation factor 2 (eIF2) and in proteins important for
releasing mRNAs from the spliceosome such as Prp22 and dead box protein 8. It
has been shown that S1 domains have specific target sequences along the RNA
(Boni et al., 1991). However, there does not seem to be any major difference from
one S1 domain to another with respect to binding of particular RNAs. The S1
domain of RNase II was successfully swapped with the S1 domains of either RNase
R or PNPase, even though there was some loss of activity (Amblar et al., 2007).
Thus it seems that the S1 domains were functioning best when in the context of the
protein with which they evolved. Further, the same study showed that neither the
degradation properties, nor the ability to deal with secondary structures were related
to the S1 domains, but the S1 domains were capable of inducing multimerization.
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A

B

Figure 3-1 Domain organization of Rrp4 and Rrp40. A. Depiction of domain organization
of the Rrp4 and Rrp40 protein sequences. The numbers indicate residue number. Arrows
above Rrp40 point to residues corresponding to disease-causing mutations in human Rrp40
(hRrp40). G8=hRrp40 G31, P36=hRrp40 V80, S87=D132, V95=hRrp40 A139,
W195=hRrp40 W238. B. A view of the exosome from the cap protein side. Shown is the
location of the cap proteins in relation to the PH ring proteins.
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Finally, both proteins have a KH domain at their C-terminal end. KH domains are
nucleic acid binding domains, fist identified in the human heterogeneous nuclear
ribonucleoprotein (hnRNP) K (Baber et al., 1999; Siomi et al., 1993). KH domains
are often found in repeats and can function either independently or cooperatively
with the other KH domains (Garcia-Mayoral et al., 2007). Like the S1 domains, they
are also conserved though evolution and are found in bacterial proteins, such as
PNPase of E. coli and also in numerous eukaryotic proteins. The best known
example is Fragile mental retardation 1(FMR1) a mutation in which causes fragile X
syndrome (Gibson et al., 1993). The KH domains are a rare case in which there are
two folds, type I and type II, that result from the highly similar sequences of the KH
motifs (Grishin, 2001). Interestingly, while Rrp4 and Rrp40 share similar structure
along their other domains, there are significant differences in their KH domain
topologies (Liu et al., 2006). The effect of these differences is not known.
Both Rrp4 and Rrp40 are essential proteins. However, given their high sequence
homology, it would be unusual that the domains are needed for the essential
function of the exosome versus having redundant roles. There are three possible
functions of Rrp4 and Rrp40. First, they may play a structural role in the assembly
of the exosome complex. When the human exosome structure was solved the
authors were unable to assemble the PH ring without including the three cap
proteins which strongly suggested that at least one of the cap proteins was needed
for the exosome to assemble (Liu et al., 2006). Second, they may bind substrate
RNA destined for degradation or processing by the exosome. This is based on the
fact that each of these proteins contains two RNA binding domains. Third, Rrp4 and
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Rrp40 may provide a platform for binding other protein cofactors of the exosome.
And finally, these three possible functions of the cap proteins are not mutually
exclusive. Therefore the purpose of this study is to determine the role of Rrp4 and
Rrp40 in the exosome.
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RESULTS

All of the domains of Rrp4 are essential
Even though both Rrp4 and Rrp40 are essential, it is not know which of their
domains are responsible for their essential role. To determine which domain of Rrp4
is responsible for the essential function, several truncations of Rrp4 were
constructed: rrp4RPL27-like, rrp4RPL27-like +S1, rrp4S1+KH, and rrp4KH which
had the RPL27-like domain, the RPL27-like + S1 domain, the S1+KH domain, and
only the KH domain respectively. Each of the truncations was inserted into a vector
with the LEU2 marker and the truncations were between the native 5’ and 3’ UTRs
of Rrp4. Two different methods were chosen to test the ability of these constructs to
substitute for the essential function of Rrp4: introducing the constructs in strains in
which Rrp4 was deleted and introducing them into a strain in which Rrp4 could be
shut-off via a galactose-regulated promoter.
First, a strain with rrp4 on the chromosome, complemented by a vector with wildtype RRP4 and an URA3 marker, was transformed with the LEU2 plasmids with the
truncations and transformants were selected on SC-Leu-Ura. Next, a plasmid
shuffle assay was carried out by growing the transformants on 5FOA to select for
strains that have lost the URA3 plasmids (for more details on the plasmid shuffle
assay refer to Chapter 2 Materials and Methods). If any truncation was able to
substitute for the essential function of Rrp4 then the strain in which it is transformed
would be able to grow on 5FOA. None of the constructs grew on 5FOA indicating
that they were unable to substitute for the essential role of Rrp4 (Figure 3-2 A).
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To confirm these results in an independent way, the same constructs were used
to transform a strain in which Rrp4 is under the control of the GAL promoter
(GAL_RRP4) allowing for shutting off the expression when glucose is added to the
medium. Transformants with truncations that were grown on medium with glucose
had a growth rate similar to the negative control (an empty vector), indicating that
they could not substitute for the essential role of Rrp4 (Figure 3-2 B). The little
growth seen for these constructs as well as for the negative control is probably due
to minimal expression from the GAL promoter allowing for low level of Rrp4. The
only construct that was able to complement the Rrp4 shut-off was the full-length
Rrp4, indicating that the truncations were not able to substitute for the essential role
of Rrp4.
To confirm that the truncated proteins were expressed, the truncations were
tagged with a TAP tag (Rigaut et al., 1999) at their C-terminal end. The TAP tag has
a Protein A moiety as a part of it, therefore expression was confirmed by a Western
blot probed with anti-Protein A antibody (Figure 3-2 C). Each truncation was
expressed to a level comparable to wild-type Rrp4 indicating that the truncations
were not viable for reasons other than lack of protein expression. A growth assay
with these TAP-tagged truncations was also conducted in rrp4 strain to verify that
the TAP tag did not alter the phenotype (Figure 3-2D). The full length TAP-tagged
Rrp4 grew as well as the untagged Rrp4 indicating that the TAP tag did not cause
alteration in the growth phenotype. Therefore the truncation and TAP tag addition
did not affect the expression and the essential role of Rrp4.
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Given all of the above data, it was concluded that all of the domains of Rrp4 are
essential for life, as none of the truncations could substitute for the essential role of
the full-length Rrp4.

All of the domains of Rrp40 are essential
To determine the essential domains of Rrp40, similar sets of experiments as for
Rrp4 were carried out. Truncations of Rrp40 were created- Rrp40RPL27-like,
Rrp40RPL27-like +S1, Rrp40S1+KH, and Rrp40KH. In the case of Rrp40, in
addition to the knock-out, and GAL-regulated Rrp40, a temperature sensitive allele
of Rrp40 was also used.
First, a plasmid shuffle assay with the Rrp40 truncations introduced into an rrp40
strain was conducted in the same way as for the rrp4strain. None of the
constructs grew on 5FOA indicating that they were unable to substitute for the
essential role of Rrp40 (Figure 3-3 A).
Second, a strain with GAL promoter regulated Rrp40 was transformed with
vectors bearing each of the truncations and was grown on medium supplemented
either with glucose or galactose. Figure 3-3B shows that only the full length Rrp40
was able to substitute for the lack of Rrp40.
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Figure 3-2. All of the domains of Rrp4 are essential. A. Plasmid shuffle assay of the
depicted truncations of Rrp4 in an rrp4 strain (Schaeffer et al., 2009). B. The depicted
truncations were transformed into a strain in which Rrpp4 is under the control of the GAL
promoter (GAL_Rrp4) and grown either without galactose (SC-Leu) or with galactose and
sucrose (SC-Leu+Gal+Suc). C. Western blot analysis of the depicted truncations of Rrp4.
D. Plasmid shuffle assay of the depicted truncations of Rrp4, TAP-tagged, in an rrp4
strain.
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Third, a strain bearing a temperature sensitive allele of Rrp40, mtr14-1, (Smith et
al., 2011) was transformed with each of the vectors encoding the Rrp40 truncations.
After selecting for transformants at room temperature, they were transferred to
either non-permissive temperature at 36oC or grown at the permissive temperature
of 23oC. As with the previous two assays, only full length Rrp40 was able to
substitute for the essential role of Rrp40 ( Figure 3-3D).
To determine if each truncation was expressed, the truncations were tagged with
a TAP tag at their C-terminus. A Western blot was conducted (Figure 3-3C) and
confirmed the expression of only the full-length Rrp40 and the truncation with only
KH domain. There was also a very low level expression of the Rrp40RPL27-like
+S1 truncation, but no visible bands for Rrp40RPL27-like or Rrp40S1+KH. The
reason why some of the Rrp40 truncations were not expressed is not known, but is
possible that factors related to proper protein folding may play a role. These data
suggest that all of the domains of Rrp44 are needed for exosome function, but in
the case of the non-expressed truncation a stability issue due to improper folding
cannot be ruled out.

The cap proteins have unique essential roles.
Because Rrp4 and Rrp40 are so similar in their domain organization, it is possible
that one of them can substitute for another. To test if each of them has a unique
role, each was overexpressed into a deletion strain of the other. Because the
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D

Figure 3-3. All of the domains of Rrp40 are essential. A. Plasmid shuffle assay of the
depicted truncations of Rrp40 in an rrp4 strain (Schaeffer et al., 2009). B. The depicted
truncations were transformed into a strain in which Rrp40 is under the control of the GAL
promoter (Gal_Rrp4) and grown without galactose (SC-Leu) and with galactose and
sucrose (SC-Leu+Gal+Suc). C. Western blot analysis of the depicted truncations of Rrp40
D. The depicted truncations were transformed into a strain with temperature sensitive
Rrp40 (Rrp40 ts) and grown at permissive (23oC) and non-permissive (36oC) temperature.
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deletions strains already have the rest of the exosome genes on their
chromosomes, the additional genes were introduced behind the strong and
inducible GAL promoter and in a 2 vector, in order to overexpress the protein. 2
vectors are high copy vectors used for high expression (Futcher and Cox, 1984).
There are two reasons for designing the assay this way. First, it is possible that
deletion of one protein, either Rrp4 or Rrp40, is stoichiometrically unfavorable and
even if the other protein can substitute for the essential function, there isn’t enough
of it available. Such situation would lower the total number of exosome complexes
in the cell to a minimum of half of the original. If however, the other protein is
overexpressed, it may be able to substitute for the essential function of the other.
Second, increasing concentration of proteins by overexpression increases their
chance of interacting with lower affinities. Therefore, even if Rrp40 has weaker
interaction with the exosome at the place of Rrp4 (and vice versa), overexpressing it
will increase the chance for interaction. Additionally, since the third cap protein Csl4,
also has a similar domain, it was also included in the assay. The transformants
were grown on 5FOA + galactose. 5FOA was used to select for transformants that
have lost the plasmid with the URA3 marker (wild-type gene) and galactose was
used to induce expression from the vector. None of the proteins were able to
substitute for any of the other two cap proteins (Figure 3-4). In each strain, the only
transformants that grew were the ones transformed with the corresponding protein
for positive control.
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Figure 3-4. Overexpression of each cap protein in a deletion strain of the other cap
proteins A plasmid shuffle assay of A. rrp4 B. rrp40 and C. csl4 strain transformed with
the indicated vectors in which each of the cap proteins was under the control of the GAL
promoter.
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The above data indicate that Rrp4, Rrp40, and also Csl4, have unique roles that
cannot be substituted by overexpressing another one of the cap proteins.

The homologous domains of Rrp4 and Rrp40 are not interchangeable
As mentioned earlier, there is a possibility that the essential role of Rrp4 and
Rrp40 is structural, functional, or both. Since the data so far indicated that each of
the domains of Rrp4 and Rrp40 is needed for exosome function, either one of these
possibilities could not be ruled out. The structural role for either Rrp4 or Rrp40
would be to bridge two dimers of the exosome PH-ring subunits. One way to check
for a structural role is to express the proteins as separate domains, in trans.
However, not all truncations of Rrp40 were stable, therefore it is impossible to
express Rrp40 in trans. Conversely, all truncations of Rrp4 were expressed at levels
comparable to wild type.
To verify that at least one of the roles for Rrp4 is structural, an in trans expression
assay was conducted. Briefly, rrp4 strain with a wild type Rrp4 on an URA3 vector
was transformed with the following truncations: one clone was transformed with
rrp4RPL27-like on LEU2 vector and rrp4S1+KH on HIS3 vector; another clone was
transformed with rrp4RPL27-like +S1 on a LEU2 vector + rrp4KH on a HIS3 vector.
The transformants were then transferred to 5FOA plates to select for los of the
URA3 (with wild-type Rrp4) vector. Neither of the two combinations of Rrp4
domains expressed in trans was able to complement an rrp4, only the full length
Rrp4 was able to complement it (Figure 3-5 A) suggesting that Rrp4 may play a
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structural role in the exosome. This is consistent with the idea that Rrp4 is important
for the exosome structure by bridging two dimers of the exosome PH-ring.
Since some of the truncations of Rrp40 were not stable on their own, we decided
to make various chimeras of Rrp4 and Rrp40. The purpose of this experiment was
to test whether the particular location of the domains was important for growth. Six
chimeric proteins were made in which various domains were combined (for
depiction see figure:3-5 B and C) rrp4 RPL27-like _rrp40S1+KH, rrp4 RPL27-like
+S1_rrp40KH, rrp40RPL27-like _rrp4S1+KH, rrp40RPL27-like +S1_rrp4KH,
rrp4RPL27-like _rrp40S1_rrp4KH, and rrp40RPL27-like _rrp4S1_Rrp40KH. Each of
these chimeras was introduced into strains with a deletion of either RRP4 (rrp4) or
RRP40 (rrp40). In rrp4, only the positive control, a plasmid bearing a full length
Rrp4, was able to complement a deletion (Figure 3-5 B) and in rrp40 only the
positive control, a full length Rp40, was able to complement a deletion (Figure 3-5
C).
Transforming chimeras in single deletion strains of either rrp4 or rrp40 has the
possibility of changing the stoichiometry of the possible exosome complex because
the resulting strain never has one of each domains. For example an rrp4 strain
transformed with a chimera rrp4 RPL27-like +S1_rrp40KH will have two KH
domains from Rrp40 and no KH domain from Rrp4. To correct for that a domain
switch experiment was also conducted in double deletion rrp4rrp40 mutants.
Neither the RPL27-like, nor the S1, nor the KH domain switch was able to
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Figure 3-5 Rrp4 and Rrp40 have a structural role in the exosome A. Plasmid shuffle
assay of the expression of Rrp4 in trans(Schaeffer et al., 2009). One of the truncations is on
a plasmid bearing a LEU2 marker, and the other on a plasmid bearing a HIS3 marker. B.
Plasmid shuffle assay of the expression of a truncation Rrp4/40 protein in an rrp4 strain.
The numbers on the pictures indicate from which proteins (4=Rrp4, 40=Rrp40) does the
indicated domain come (Schaeffer et al., 2009). C. Plasmid shuffle assay of the expression
of a truncation Rrp4/40 protein in an rrp40 strain (Schaeffer et al., 2009). D Plasmid
shuffle assay of the expression of Rrp4 and Rrp40 in which a domain has been switched.
Indicated domains are noted on the left (NT=N terminal domain, S1 domain, or KH domain)
in a double deletion strain rrp4rrp40
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complement the double deletion of Rp4 and Rrp40. The inability to switch domains
also suggests that there is a structural role for Rrp4 and Rrp40.

A conserved phosphorylation is not important for the essential role of Rrp4 or
for the nonstop mRNA surveilance by the exosome.
A conclusion that Rrp4 and Rrp40 have structural roles, does not rule out the
possibility that they also have functional roles. Both proteins have RNA binding
domains suggesting that they bind RNA that is to be degraded by the exosome. To
further look into a possible functional role, a search of two phosphorylation
databases (PhospoPep and PhosphoGRID) was performed for possible
posttranslational modifications. There was no evidence that Rrp40 was
posttranslationally modified, however Rrp4 did have several predicted
phosphorylation sites, specifically S28, S46, S152, S256, and S268. Only one of
these phosphorylation sites, S152, was also found to be conserved in human and
murine Rrp4 homologues and is located in the S1 domain close to where RNA
enters the central channel of the exosome (Synowsky et al., 2006). This suggested
that this particular modification was important for function. In order to test if this
modification was important for viability residue 152 was mutated to alanine to mimic
the phosphor-free state and to glutamic acid to mimic the phosphorylated state.
Both mutants grew at wild-type level indicating that neither mutation affected the
essential role of Rrp4 (Figure 3-6 A). These mutations were also tested by a
nonstop assay to determine if they affected the cytoplasmic surveillance role of the
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exosome. Briefly, an rrp4 strain yAV1104 with the Rrp4 phosphorylation mutants
on a plasmid was transformed with a plasmid with a HIS3 gene in which the stop
codon is mutated (his3-nonstop) pAV188. The transformants were then grown with
and without supplemented histidine in the medium. If the his3-nonstop mRNA is
recognized as aberrant by the exosome, then it is quickly degraded. Thus, that
strain will not grow on medium lacking histidine. If, however, there is a problem with
cytoplasmic nonstop mRNA degradation, then the his3-nonstop mRNA will not be
degraded, and a protein will be translated which will then allow for growth on
medium lacking histidine. Figure 3-6 B shows that there is no growth of either point
mutant indicating that there is no effect on the cytoplasmic mRNA degradation of
nonstop mRNA by the exosome. Taken together, these data indicate that this
conserved site of Rrp4 is not important for the essential role of Rrp4 or for the
nonstop mRNA surveilance of the exosome.

Excess Rrp4 is stable
Some studies have suggested that exosome subunits localize to different sites in
the cell. Specifically, by using indirect immunofluorescence with antibodies to
endogenous exosome subunits, it was found that in Drosophila melanogaster S2
cells, various exosome components localize differently (Graham et al., 2006). The
authors concluded that there may be differently assembled exosome complexes.
However, a careful analysis of their data shows that Rrp4 was enriched in foci that
were markedly different from the foci seen for Rrp40 and Rrp42 (a PH ring subunit
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Figure 3-6. The posttranslational phosphorylation of Rrp4 is not important for
viability or nonstop mRNA degradation. A. Plasmid shuffle assay of point mutants of
Rrp4 S152E and S152A. Two independently derived clones of each mutant were plated.
The location of S152 along the Rrp4 protein sequence is indicated with an asterisk on the
picture below. B. Non-stop assay (see material and methods) of the same mutants in an
rrp4 strain.
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of the exosome) suggesting that Rrp4 may have a role outside of the exosome,
since it does not localize with a PH ring subunit. Presumably, if such a role exists,
Rrp4 would be stable on its own, not as a part of the exosome complex.
To test if Rrp4 is stable when not associated with the exosome, several
experiments were completed. First, a wild-type strain was transformed with a
plasmid encoding full-length, TAP- tagged Rrp4 with a URA3 marker
(Rrp4_TAP,URA) and a high copy plasmid with GAL regulated full-length Rrp4ProteinA with an LEU2 marker( GAL_Rrp4-PtnA, LEU2). The purpose of the
experiment was to overexpress Rrp4 via the plasmid with the GAL promoter, and to
verify the level of the total Rrp4 by a Western blot with an anti-Protein A antibody
that detects the Protein A in the high copy vector and the TAP tag. If Rrp4 is not
stable when not associated with exosome, it would be expected that the levels of
the antibody detectable (i.e. TAP-tagged + Protein A tagged) Rrp4 would be the
same compared to a strain in which there is no GAL_Rrp4-PtnA. However, the
levels of Rrp4 increased (Figure 3-7 A). The increase seen in the Western blot is
due to a Protein A moiety that is cloned in frame with the Gal_RRP4 gene, resulting
in the expression of a Protein A-tagged Rrp4. These data suggest that Rrp4 is
stable out of the exosome.
A second experiment to address the stability of Rrp4 when not in the exosome
complex was completed. A vector with a Tap-tagged Rrp4 with a LEU2 marker
(Rrp4_TAP, LEU2), was introduced either in wild-type S. cerevisiae strain or in an
rrp4 strain, complemented with a wild-type RRP4 allele on a vector with a URA3
marker (Rrp4, URA3). The strains were then grown on 5FOA to select for the loss of
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the URA3 vector in the rrp4 strain. Therefore after plasmid shuffle both strains
have the Rrp4_TAP vector, but the wild-type strain has a chromosomally originating
wild-type Rrp4 while the rrp4 strain doesn’t. As seen in Figure 3-7 B, both strains
have the same amount of Rrp4_TAP even though the wild-type strain has the wildtype Rrp4 on the chromosome. These data also suggest that Rrp4 is stable out of
the exosome complex.
A third experiment was completed for an additional confirmation of the stability of
Rrp4 out of the exosome complex. This experiment utilizes temperature sensitive
mutants of components of the cap, the PH ring, and the catalytic subunit. The
mutants were a temperature-sensitive mutant of Mtr3, mtr3-1, a temperaturesensitive mutant of Rrp40, mtr14-1, and a temperature sensitive mutant of Rrp44,
mtr17-1. These mutations were discovered as a part of a screen for mutants
defective in nuclear mRNA export (Kadowaki et al., 1994). Each one of these
strains and a wild-type strain were transformed with a vector with Rrp4_TAP and
incubated at permissive (23oC) and non-permissive (37oC) temperature and then
the amount of Rrp4_TAP was determined and compared. As seen from the results
in Figure 3-7 C, there was no change in the amount of Rrp4_TAP in any of the
strains at both temperatures. The results of this assay taken together with the first
two experiments suggest that when Rrp4 is in excess, it is stable.
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Figure 3-7 Rrp4 is stable out of the exosome complex. Western blots probed with either
anti-ProteinA antibody (PtnA) or anti-Pgk1 for loading control. A. Wild-type S. cerevisiae
strain, transformed with a plasmid with Rrp4_TAP and either GAL_Rrp4-PtnA or empty
vector. B. Rrp4_TAP was introduced to either WT (ln1) or rrp (ln2) strain. Ln3 is a
negative control WT+ vector. C. Temperature sensitive strains (listed below the Western
blots) were transformed with an Rrp4_TAP and grown at the indicated temperatures. –
(very right lane) is WT strain transformed with an empty vector control, grown at 23oC.
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DISCUSSION
The data presented in this chapter begin to uncover the possible roles of the two
RNA binding proteins Rrp4 and Rrp40. I have determined that the essential function
of Rrp4 and Rrp40 does not lie only in one domain, but rather expression of the
entire proteins is necessary for life. Additionally, Rrp4 and Rrp40 have unique roles
that cannot be substituted by the other one, despite having such a similar domain
organization. However, the data about the unique domain roles may not be valid
because after this study was concluded, a new crystal structure of the exosome was
published where the domain organization of Rrp4 and Rrp40 was changed (Makino
et al., 2013). In particular there is a large difference of the boundaries of the S1
domain of Rrp40 which may have affected the results of the S1 domain switch
(Figure 3-8).
One line of evidence presented here points to a structural role for both Rrp4 and
Rrp40. First, both the RPL27-like and the KH domains of Rrp4 and Rrp40 are
essential. Second, the RPL27-like domain of Rrp4, which interacts with Rrp41, and
the RPL27-like domain of Rrp40, which interacts with Rrp46 are not
interchangeable. The KH domains of both proteins are also not interchangeable.
The KH domain of Rrp4 interacts with Rrp42, and the KH domain of Rrp40 interacts
with Rrp43. Third, at least for Rrp4 I have established that the RPL27-like and the
KH domains need to be in the same polypeptide. These data, taken together with
data from other studies, specifically that the cap proteins were needed for the
assembly of the exosome complex (Liu et al., 2006), indicate that Rrp4 and Rrp40
are needed to provide bridging contacts for the underlying PH ring proteins. After
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B

Figure 3-8. Revised domain organization of Rrp4 and Rrp40. A. Domain organization of
Rrp4 and Rrp40 according to the crystal structure published by (Makino et al., 2013).
B. Domain organization of Rrp4 and Rrp40 used to create the truncations used in this
study.
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this study was concluded, a study was published of reconstitution of the exosome,
where the authors show that in vitro only Rrp40 was needed for the assembly of the
PH ring of the exosome (Malet et al., 2010). While these data support my
conclusion about the structural role of Rrp40, it does not support a model for a
structural role for Rrp4. However, since this study was carried out in vitro, it is still
possible that Rrp4 has a structural role, but that the exosome exists in vivo in two or
more conformations. Another possible explanation is that Rrp4 may be added late
during exosome assembly or it may be transiently associated with the exosome.
Such unstable association may also explain the stability of Rrp4 out of the exosome
complex, which is discussed below.
The presence of multiple RNA binding domains at the site of RNA entry into the
exosome, points to a functional role for Rrp4 and Rrp40, specifically, binding of
exosome’s substrates. Point mutations of three basic residues in a loop in the S1
domain of Rrp4 were lethal suggesting that the essential role of Rrp4 is as a part of
the exosome because the S1 domain binds RNA destined for degradation (Malet et
al., 2010).
Additionally, Rrp4 seems also to have a functional role outside of the exosome
complex. This conclusion is based on two separate pieces of data. First, Rrp4 has
been shown to localize to distinct foci in D. melanogaster (Graham et al., 2006).
Second, my data show that Rrp4 it not degraded when in excess. What this
functional role is, is currently unknown. However, other exosome components have
also been found to have a role outside of the complex. For example, Rrp46 was
found to assemble in dimers, in addition to its assembly in the exosome (Yang et
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al., 2010). Therefore it is possible that Rrp4 also has exosome independent roles.
Future studies may address this possibility. The phosphorylation of Rrp4 suggest
that there may be an additional regulation needed, for some other role of Rrp4, but
that this possible role is non-essential given the fact that the phosphorylation itself
was not essential. The phosphorylation site however was next to the essential basic
residues that were found to be essential. It would be interesting to determine what if
any regulation the phosphorylation of Rrp4 exerts on the proteins and what is the
role of Rrp4 outside of the exosome.
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Chapter 4. Characterization of the exosome cap protein Csl4
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INTRODUCTION
Csl4 is one of the cap proteins of the exosome, together with Rrp4 and Rrp40.
Csl4 was first identified in a screen for Cep1 synthetic lethality (Baker et al., 1998).
Prior to that, a separate screen for viral super killer mutants identified eight socalled Ski proteins (Toh et al., 1978). It was later discovered that Csl4 is
homologous to one of the genes identified in the superkiller screen, Ski4, and that it
is a component of the exosome (Allmang et al., 1999b; van Hoof et al., 2000b).
The exosome associates with different proteins in the nucleus and in the
cytoplasm and it is believed that these associations determine the specificity of
substrate degradation or processing. However, the mechanism of these cofactor
associations remains unknown. Csl4 is the only protein of the exosome complex
which is currently known to have a mutation specifically disturbing cytoplasmic
mRNA degradation, both for normal and nonstop transcripts. Therefore, Csl4 is a
likely candidate to mediate the different roles of the exosome in the nucleus and in
the cytoplasm.
Csl4 consists of three domains. The N-terminal domain is structurally related to
ribosomal protein L27. In the middle of the protein there is an S1 domain which is
an RNA-binding domain. The C-terminal domain is a Zn ribbon-like domain, which is
structurally similar to Zn ribbons, but it lacks the cysteine residues characteristic of
Zn ribbons. Therefore it does not bind Zn (Figure 4-1). For more detailed
information on the RPL27-like and S1 domains in general, please refer to Chapter
3. In the Zn-ribbon domain of the archaeal homolog of Csl4 the cysteine residues
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are present and thus archaeal Csl4 is likely to bind a Zn atom (Buttner et al., 2005).
In S. cerevisiae Cslp4 also has a linker region between the RPL27-like domain and
the S1 domain, which is absent from its human homolog. A point mutant csl4-1, in
the promoter of Csl4, reduces expression of Csl4 and has been found to be
defective in rRNA processing while the cytoplasmic mRNA degradation function of
the exosome was not affected (van Hoof et al., 2000b). Another mutant, ski4-1, has
a point mutation G253E located in the Zn ribbon-like domain and is defective in
mRNA degradation but has normal rRNA processing phenotype (van Hoof et al.,
2000b). These two mutants in effect separate the role of the exosome in the
nucleus from its role in the cytoplasm.
Two general possibilities were considered when aiming to identify what was the
essential role of Csl4. First, Csl4 could have a structural role in stabilizing the
exosome complex. When the crystal structure of the human exosome complex was
solved, the authors reported unsuccessfully trying to assemble just the PH ring
without the cap proteins Csl4, Rrp4, and Rrp40. They were only able to assemble
the entire complex once the cap proteins were added (Liu et al., 2006). This
suggested that the cap proteins, one of which is Csl4, could play a structural role in
the assembly of the complex. It was not further investigated whether all of them or
only particular ones were needed for the exosome assembly. A second possible
role for Csl4 is that it could have a functional role on the exosome complex. No
enzymatic activity has been identified for Csl4, however it contains potential nucleic
acid binding domains (S1 and Zn-like) and a possible protein-binding domain
(RPL27-like), and it is located at the site of the proposed entry of substrate into the
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exosome (Wang et al., 2007). It is known that the exosome functions with various
protein cofactors but the locations of interactions between these cofactors and the
exosome are unknown. Therefore is it possible that Csl4, being located at the
proposed entry site of the substrate, mediates entry of the substrate into the
exosome central channel by interacting with other protein factors, binding
substrates, or both. This chapter outlines the experiments that were carried out in
order to identify and distinguish these possible role of Csl4.

72

Figure 4-1 Domain organization of Csl4. Csl4 has three domains; the RPL27-like domain
is the N-terminal domain, followed by a linker region which is not present in human
homologues, an S1 domain and the a Zn ribbon-like domain. Numbers indicate residues.
Point mutants csl4-1 is located in the promoter as depicted, and ski4-1 is located in the Zn
ribbon-like domain.
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RESULTS
Csl4 does not stabilize the exosome by bridging contacts
To determine which domain of Csl4 is essential, C-terminal truncations of Csl4
were created and used in a plasmid-shuffle assay (for details of the assay see
materials and methods). Briefly, a csl4 strain was transformed with plasmids with
either wild-type Csl4 or truncated Csl4. The truncations used were Csl4 1-120
(RPL27-like+linker), Csl4 1-250(RPL27-like +linker+ S1 domains), Csl4 65292(linker + S1+Zn ribbon-like domains), and 120-292(S1 + Zn ribbon-like
domains). Transformants were selected on SC-Leu-Ura. Next, a plasmid shuffle
assay was performed on 5FOA to determine if any of the truncations could
substitute for the essential role of Csl4. It was found that the RPL27-like+linker
domain was sufficient for viability even after removing the Zn ribbon-like domain and
the S1+ the Zn ribbon-like domains (Figure 4-2A). However, based on Csl4’s
buried surface from the crystal structure of the human exosome, the RPL27-like
domain should only interact with one of the PH ring subunits, Mtr3 (Liu et al., 2006).
Therefore a truncation that only interacts with one subunit cannot bridge the
underlying proteins. These data suggested that the essential role of Csl4 was not in
stabilizing the exosome by bridging contacts between the PH subunits. In
confirmation of these results, a paper published in 2007 also indicated that the
yeast exosome can be assembled without Csl4 in vitro (Wang et al., 2007).
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The RPL27-like domain and the S1+ Zn ribbon-like domains are redundant for
the essential function of Csl4
To further confirm which domains were essential for the role of Csl4, N-terminal
truncations of Csl4 were also created and used in a plasmid shuffle assay.
Surprisingly, the RPL27-like domain was not essential and viability was conferred
as long as the S1+ Zn ribbon-like domains were expressed in cis (Figure 4-2 A).
The Zn ribbon-like truncation did not grow (not shown). To clarify whether the S1 or
the Zn ribbon -like domain contributed to the essential role in the Csl4-S1+Znribbon-like truncation, the S1 domain was expressed by itself and was found not to
be sufficient for life (Figure 4-2 B ). Therefore, the S1+Zn ribbon-like domains were
also sufficient for viability.
Expression of the truncations was checked by Western blot using TAP-tagged
truncations and all but the Zn ribbon-like domains were found to be expressed
(Figure 4-2 C). Because the Western blot was done using TAP-tagged truncations
of Csl4, but the initial growth assay was done using untagged truncations, it was
also verified by a growth assay that the addition of the TAP tag did not alter the
phenotype of the viable mutants (Figure 4-2 D). The above data indicate that the
RPL27-like domain and the S1+ Zn ribbon-like domains are redundant for the
essential function of Csl4. This is consistent with a view that if an exosomeinteracting domain of Csl4 is expressed the essential function of Csl4 can be carried
out.
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Figure 4-2. The RPL27-like domain and the S1+ Zn ribbon-like domains are
redundant for the essential function of Csl4. A and B Plasmid shuffle assay. csl4 strain
was transformed with plasmids with the indicated truncations and LEU2 markers. C. A
Western blot of the depicted TAP-tagged truncations of Csl4. PGK1- loading control. D.
Plasmid shuffle assay. csl4 strain was transformed with plasmids with the indicated
truncations with a C-terminal TAP tag and LEU2 markers.
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Because it was determined that Csl4 does not stabilize the exosome by bridging
interactions, to further characterize its role (both essential and non-essential),
several possibilities were addressed using the viable truncations of Csl4. First, the
nuclear function of the exosome was tested; second, the cytoplasmic function of the
exosome was tested; third, posttranslational modifications were tested; fourth,
conserved surface residues were mutated.

The ZN ribbon-like domain is required for the known functions of the
cytoplasmic exosome.
To correlate the growth data with known biological roles of the exosome, the
domains of Csl4 that were found to sustain viability, were tested for the known
nuclear roles of the exosome. Specifically, I tested the 7S pre-rRNA processing and
5’ ETS degradation, which are known to be affected in exosome depletions
(Allmang et al., 1999a). The processing of the 7S pre-rRNA was slightly affected in
the truncation bearing only the RPL27-like domain, but unaffected in other viable
truncations. There was no effect on the final 5.8S rRNA processing and on the
degradation of the 5’ ETS (Figure 4-3). This indicated that viable Csl4 truncations
behaved almost as wild type in rRNA degradation and processing.
The same domains were also tested for known cytoplasmic exosome roles,
specifically cytoplasmic mRNA degradation and nonstop mRNA degradation.
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Figure 4-3 Viable truncation of Csl4 behave as wild type for rRNA processing and
degradation. Northern blot analysis of csl4 strain transformed with the indicated
truncations. The RNA for which it was probed are listed on the left of the pictures. SRP (the
RNA moiety of the signal recognition particle) is used as a loading control.
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Figure 4-4 Cytoplasmic mRNA degradation and nonstop mRNA surveillance by the
viable Csl4 truncations. A. Cytoplasmic mRNA degradation assay of the depicted
truncations B. nonstop assay of the depicted truncations.
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Briefly, to completely abolish cytoplasmic mRNA degradation, which is essential,
both 5’3’ and 3’5’ degradation pathways must be blocked. A strain with a
temperature sensitive mutation dcp1-2 and a mutation ski4-1 was used. The ski4-1
mutation blocks the 3’5’ mRNA degradation pathway. The dcp1-2 mutation
conditionally blocks the 5’3’ mRNA degradation pathway when transferred to nonpermissive temperature. For description of the assay, see Chapter 2 “Materials and
methods”. The dcp1-2 ski4-1 mutant was transformed with vectors encoding viable
truncations of Csl4 and then grown at permissive and non-permissive temperatures.
At the non-permissive temperature both pathways for mRNA degradation are
blocked and this strain can only survive if a truncation of Csl4 can substitute for the
mRNA degradation role of wild-type Csl4. As seen in Figure 4-4 A, truncations
lacking the Zn ribbon-like domain did not survive, while other truncations did,
indicating that the Zn ribbon-like domain is required for mRNA degradation by the
exosome. Additionally, the truncations were tested for nonstop mRNA surveillance
by the exosome. A csl4 strain supplemented by truncations of Csl4 were
transformed with a vector carrying a HIS3 gene lacking a stop codon (his3-nonstop)
and grown with and without histidine. Only the truncations lacking the Zn ribbon-like
domain grew on medium lacking histidine, indicating that the Zn ribbon - like domain
is required for nonstop mRNA degradation by the exosome. Therefore, the Zn
ribbon-like domain of Csl4 is required for all known cytoplasmic roles of the
exosome.
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Posttranslational phosphorylaiton at S94 is not important for the essential
role Csl4.
To continue looking into the role of Csl4, a search of PhospoPep and
PhosphoGRID phosphorylation databases was performed for possible
phosphorylation sites. It was found that Csl4 could potentially be phosphorylated in
the linker between the RPL27-like and the S1 domain, at residue S94 (Synowsky et
al., 2006).To test if the phosphorylation was required for viability, residue 94 was
mutated to alanine and to glutamic acid to mimic the phosphor-free and the
phosphorylated state. Both mutants were able to substitute for the essential role of
Csl4, indicating that this particular potential posttranslational modification was not
required for viability (Figure 4-5).

The Zn ribbon-like domain is essential in the absence of the RPL27-like
domain
While expressing the S1 and Zn ribbon-like domains together was sufficient for
viability, expressing either one by itself was not. To determine which domain, S1 or
Zn ribbon-like, carried the essential function, 23 conserved amino acids were
mutated in either the S1 or the Zn ribbon-like domain. All of the mutations were
created in a truncation of Csl4 which lacks the RPL27-like domain because the
RPL27-like domain is viable on its own as determined previously. Therefore its
presence on its own confers viability. All of the amino acids were changed to
alanine. There were four double mutants in the S1 domain: V210A R211A, D214A
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Figure 4-5. The posttranslational phosphorylation of Csl4 is not important for the
essential role Csl4. Plasmid shuffle assay of point mutants of Csl4 S194A and S94E. The
location of S94 along the Csl4 sequence protein sequence is indicated with an asterisk on
the picture above.
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Figure 4-6 The Zn ribbon-like domain is essential in the absence of the RPL27-like
domain. Plasmid shuffle assays of the indicated truncations. Strain, cls4, is indicated in
the left upper corner, the mutations are indicated at the left of each picture, medium
indicated above the picture of each growth assay A. Point mutants of residues located in
the S1 domain in truncations lacking the RPL 27 domain. B. Point mutants of residues
located in the Zn ribbon-like domain. D. Point mutants of residues located in the Zn ribbonlike domain in truncations with or without the RPL27-like domain C. A Western blot of TAPtagged truncation of Csl4 lacking the RPL 27 domain with the indicated point mutations
above each blot.
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R215A, D216A R217A, and S236A L237A. All of these mutants were viable as
determined by a plasmid shuffle assay (Figure 4-6 A) suggesting that the S1
domain was not essential for viability. To check if the Zn ribbon-like domain was
essential for viability, nine mutants were created in the Zn ribbon-like domain:
D251A L252A, G253A, V254A V255A, M267A, W272A, Y268A T270A W272A,
M275A P278A, E284A R286A K287A, and K290A. With the exception of W272A
and K290A, all of the rest of the mutations were lethal (Figure 4-6 B). To confirm
that the lack of growth was due specifically to the point mutations, and not due to
lack of expression, the expression of these mutants, except W272A which was
viable, was confirmed by a Western blot (Figure 4-6 C). Addition of the RPL27-like
domain to the Y268A T270A W272A mutant, restored viability suggesting that the
RPL27-like domain and the Zn-ribbon domain may have a functional redundancy for
the essential role of Csl4 (Figure 4-6 D). Overall, these data indicate that in Csl4 the
Zn ribbon-like domain is essential in the absence of the RPL27-like domain.

The essential role of the Zn ribbon-like domain in the absence of the RPL27like domain overlaps with its role in mRNA degradation and nonstop mRNA
decay.
To determine if the essential role of the Zn ribbon-like domain in the absence of
the RPL27-like domain was specific to the nuclear exosome, the cytoplasmic
exosome function was also tested. Each of the nonviable truncations was
transformed into a double mutant dcp1-2 ski4-1 and after selection for
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Figure 4-7. Point mutations in the Zn ribbon-like domain are defective in mRNA
degradation in the absence of RPL 27 domain. A and B. mRNA degradation growth
assays of the indicated point mutations in the S1+Zn ribbon-like truncation of Csl4.
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transformants, grown at permissive and non-permissive temperatures. Each of the
mutants that was not able to substitute for the essential role of Csl4 was also not
able to substitute for mRNA decay function (Figure 4-7 A and B). In contrast, the
mutant that was viable, K290A, was also able to substitute for the mRNA decay
functions. These results suggest that the essential role that the Zn ribbon-like
domain carries out in the absence of the RPL27-like domain, overlaps with its
cytoplasmic roles in mRNA degradation and nonstop mRNA decay.

Localizing the Zn ribbon-like domain to the exosome is not sufficient for the
essential role of Csl4
One possible explanation of the data presented above is that the Zn ribbon-like
domain has an important function and that the S1 domain may allow it to carry out
this function by recruiting the Zn ribbon-like domain to the exosome. To test this
hypothesis, the Zn ribbon-like domain of Csl4 was fused to the N-terminus of Rrp40
(Zn-Rrp40). The reason for designing the chimera in this manner, versus fusing it to
the C-terminus, was that the N-terminus of Rrp40 is the domain at which Rrp40
interacts with the Zn ribbon-like domain of Csl4.Therefore this chimera is expected
to localize the Zn ribbon-like domain to the site where it is usually positioned on the
exosome. A vector with the Zn-Rrp40 chimera was transformed into a cl4 strain
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A

B

Figure 4-8 Csl4’s essential role may not be as a part of the exosome complex. A.
Plasmid shuffle assay of the indicated chimeras in csl4 and rrp40 strains. B. A Western
blot of Co-immunoprecipitation of Myc-tagged Rrp43 with TAP-tagged Csl4 truncations.
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and also into an rrp40 strain and after selecting for transformants, both stains with
appropriate controls were grown on 5FOA for a plasmid shuffle assay. The ZnRrp40 chimera was able to complement an rrp40 strain indicating that the protein
is expressed (Figure 4-8 A bottom 3 lanes). However, the Zn-Rrp40 chimera was
not able to complement a csl4 strain, indicating that localizing the Zn domain to the
exosome was not sufficient for viability (Figure 4-8 A).

Multiple domains contribute to Csl4 association with the exosome
Multiple domains were found to be sufficient for viability; however it was not clear
if each of them was required for localization to the exosome. Therefore, an
experiment was carried out to test which domain of Csl4 was required for
localization to the exosome. TAP-tagged Csl4 truncations were transformed into a
strain with a Myc-tagged Rrp43. Co-immunoprecipitation was performed with
Protein A beads and then a Western blot was performed on the total protein extract
and the bound fraction. As seen in Figure 4-8 B, Rrp43 only interacted with the full
length Csl4, but not with any of the other otherwise viable truncations, suggesting
that these truncations were not interacting with the core exosome. This indicates
that more than one domain is necessary for the association of Csl4 with the
exosome.
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DISCUSSION
The data presented in this chapter uncover at least partially the possible roles
Csl4 may play in the exosome. Given the fact that the other two exosome proteins,
Rrp4 and Rrp40 were determined to have structural roles, it is interesting that Csl4
does not seem to bridge PH ring subunits of the exosome. This is despite the fact
that two of its three domains are very similar and it is also located at the same side
of the exosome at the RNA entry. Other studies have found that Csl4 is not as
tightly associated with the exosome as Rrp4 and Rrp40, further supporting the idea
that it does not stabilize the exosome by bridging interactions, but instead has a
functional role (Synowsky et al., 2006). The potential phosphorylation site found on
Csl4 at residue S94 suggests that there may be some regulation, however no effect
on cell viability was discovered suggesting that regardless of the regulation (if any)
this modification does not involve the essential role of Csl4. After the conclusion of
this study a new crystal structure of the exosome was published(Makino et al.,
2013). Therefore the domain organization of Csl4 was revised (Figure 4-9).
However, the changes to Csl4 were very slight and considering how the truncation
were made (see Chapter 2, Table 2-2) should not have any effect on the
conclusions based on the experiments in this chapter.
In addition to its essential and likely nuclear role, Csl4 also has a cytoplasmic role
and the Zn ribbon-like domain was found to be required for it. A mutant ski4-1,
which has a point mutation in the Zn ribbon-like domain of Csl4, cannot do
cytoplasmic mRNA degradation (van Hoof et al., 2000b). However how it exerts its
effect was not known. This point mutation is only four amino acids away from the S1
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A

B

Figure 4-9. Revised domain organization of Csl4. A. Domain organization of Csl4
according to the crystal structure published by (Makino et al., 2013). B. Domain orgnizaiton
of Csl4 used to create the truncations used in this study.
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domain; therefore it was possible that alteration in the S1 domain, not the Zn ribbonlike domain was responsible for this effect. The data presented here indicate that it
is the Zn ribbon-like domain that is required for cytoplasmic mRNA degradation and
also for nonstop mRNA decay because a truncation lacking the Zn ribbon-like
domain, but containing the entire S1 domain did affect the cytoplasmic role.
A very intriguing finding is that while Csl4 is an essential protein, it does not
contain a single essential domain. Viability is conferred as long as either the RPL27like domain or the S1+Zn domain are expressed. This suggests that whatever the
essential function of Csl4 is, these two distinct parts of the protein must be able to
perform it. Each of these two parts of Csl4 interacts independently with the
exosome. It is therefore possible that a protein cofactor or RNA interact
independently with separate moieties on Csl4 and when only one or the other is
expressed there is still residual interaction capable of carrying out the essential
function of Csl4 (Figure 4-10).
Looking to further narrow down which domain of the S1+Zn truncation actually
carries out the essential role of this truncation, it was found that in fact it was the Zn
ribbon-like domain. This conclusion was based on the fact that mutations in
conserved residues along the Zn ribbon-like domain were inviable, while point
mutations along conserved residues in the S1 domain did not affect viability. These
same mutations also affected the non-essential cytoplasmic roles of Csl4 in normal
mRNA decay and nonstop mRNA degradation.
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.
Figure 4-10. Model for interaction of Csl4 with a protein co-factor or RNA. A protein
cofactor or RNA that are required for the essential role of Csl4 interacts with both the
RPL27-like and the Zn ribbon-like domain and interaction with the exosome is also required
for viability. On the bottom left is a depiction of the truncations that were sufficient for
growth and on the bottom right is a depiction of the truncations that were not sufficient for
growth.
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One interpretation of these data is that the point mutations of conserved residues
affect the structure of the Zn ribbon-domain rendering it non-functional. Another
possibility is that these residues are important for contact and stable interactions
with a protein cofactor or RNA substrate which are weakened even further in the
absence of the RPL27-like domain. Finally a combination of these interpretations
may be what is actually going on and some mutations may affect structure while
others may affect binding. Regardless of that, it is the Zn ribbon-like domain that
overlaps with the RPL27-like domain for the essential role of Csl4. However, the Zn
ribbon-like domain had to be expressed together with the S1 domain. The S1
domain is where the S1+Zn interact with the exosome. That is consistent with a
model in which RNA or protein cofactor(s) bind two separate ends of Csl4 and need
to be brought to the exosome, and in this case the S1 domain may be fulfilling that
role.
Csl4 may participate in a mixed RNA-protein interaction in addition to binding
exclusively RNA or proteins. For example archaeal Csl4 is required for interaction of
the exosome with DnaG in order to improve interaction with A-rich RNAs (Hou et al.,
2013). Csl4 is capable of binding both RNA and protein, Rrp6, on different surfaces
(Makino et al., 2013). Therefore it is possible that there is more than one essential
role for Csl4 and it binds RNA for one and proteins for a different essential role.
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Chapter 5: The exoribonuclease of Rrp44 affects iron response

Disclaimer: This chapter includes experiments completed by other people. The microarray
and the calculations of mRNA levels were completed in the laboratory of Dr. Allan
Jacobson, University of Massachusetts. The PARE analysis was completed in the
laboratory of Dr. Pamela Green at the University of Delaware.
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INTRODUCTION
Structural organization of Rrp44, the catalytic subunit of the RNA exosome

Rrp44 is the only catalytically active subunit of the exosome (Dziembowski et al.,
2007; Liu et al., 2006). It has a 3’5’ exonuclease activity and an endonuclease
activity (Dziembowski et al., 2007; Greimann and Lima, 2008; Lebreton et al., 2008;
Schaeffer et al., 2009; Schneider et al., 2009). All known exosome activities are
affected in an exonuclease point mutant, but not in an endonuclease point mutant.
These include nuclear roles such as processing of 5.8S rRNA and snoRNAs and
degradation of the 5’ ETS of rRNA (Allmang et al., 1999a; Mitchell et al., 1996; van
Hoof et al., 2000a). In addition, cytoplasmic degradation of normal mRNAs also
seems to be affected only in the exoribonuclease mutant (Schaeffer and van Hoof,
2011). In the case of cytoplasmic nonstop mRNA degradation the exonuclease and
the endonuclease domains are redundant, but still, there is no known substrate that
is specific only to the endonuclease (Schaeffer and van Hoof, 2011)
Rrp44 has 5 domains. From the N to the C terminus the domain organization is as
follows: there is a PIN domain which harbors the endonuclease activity, two cold
shock (CSD) domains CSD1 and CSD2, an RNB domain which has the 3’5’
exoribonuclease activity, and an S1 domain which is an RNA binding domain
(Figure 5-1). In addition, at the very N-terminus of the protein there is a conserved
region of 33 amino acids followed by a CR3 region which consists of three
conserved cysteine residues (Cairrao et al., 2005; Schaeffer et al., 2012). Each of
the domains of Rrp44 is found both in eukaryotic and prokaryotic organisms and
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with the exception of the PIN domain, the rest of the domains are shared between
Rrp44 and its bacterial homologues RNase II and RNase R (Amblar et al., 2006;
Vincent and Deutscher, 2009). Point mutants are available that completely
inactivate the catalytic activities of the exosome. A point mutation D171A completely
abolished the endonuclease activity (Schaeffer et al., 2009), while a point mutant
D551N eliminates the 3’5’ exoribonuclease activity (Dziembowski et al., 2007).
Rrp44 contacts the exosome at the site opposite of the RNA binding proteins (see
Chapter 1, Figure 1-1). RNA that is threaded through the PH ring reaches the RNB
domain of Rrp44 where it is hydrolytically degraded in the 3’5’ direction. The
exonuclease faces the central channel and thus any substrate that emerges from it,
suggesting that RNA that goes through the channel is destined for exoribonuclease
degradation. It is not clear however why the endonuclease faces away from the
central channel (Chapter1, Figure 1-1). Studies suggest that the RNA is delivered to
the endonuclease through the central channel as well, since mutations in the
central channel were shown to affect the activity not only of the exonuclease, but
also of the endonuclease (Drazkowska et al., 2013; Wasmuth and Lima, 2012)
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Figure 5-1. Domain organization of Rrp44. The domains of Rrp44 are depicted.
Locations of the nuclease point mutants are shown above the protein and the part of Rrp44
that is homologous to RNase II and RNase R is shown below the protein.
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While Rrp44 is the only catalytic subunit of the eukaryotic exosome, it may not
always be associated with the exosome. For example, there are three proteins that
are homologues of Rrp44 in humans, and they localize to different cellular
compartments (Tomecki et al., 2010). In S. cerevisiae and in Drosophila
melanogaster Rrp44 is not as tightly associated with the exosome as the rest of the
subunits (Allmang et al., 1999b; Graham et al., 2009a). An Rrp44 mutant that has
the N-terminus deleted does not associate with the exosome (Schneider et al.,
2009). Studies in Arabidopsis thaliana and in trypanosomes did not find that Rrp44
associates with the exosome, however it is still possible that in vivo Rrp44 does in
fact associate with the exosome in these organisms (Chekanova et al., 2002;
Estevez et al., 2001). Finally, microarray studies on knock downs of Rrp44, Rrp6,
and core exosome subunits, showed that the substrates of each differed suggesting
again exosome independent roles for these proteins (Kiss and Andrulis, 2010).
Regardless of whether it does or it doesn’t have exosome independent functions,
Rrp44 does provide the catalytic activity of the exosome thus it is important for all of
the exosome’s functions.

Functional studies of Rrp44 and the exosome
Most studies of the exosome and Rrp44 have concentrated on substrate
specificities and structure, thus functional studies are limited. However there are
several studies that associate the exosome and Rrp44 with particular cellular roles.
Rrp44 has been found to alter circadian rhythm in Neurospora crassa (Guo et al.,
2009). Yeast Rrp44 mutant has also been found to have a defect in microtubules
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(Smith et al., 2011). Finally, a study showed that Rrp44 affects chromosome
segregation and mitotic progression in Schizosaccharomyces pombe by affecting
kinetochore formation and kinetochore-microtubule interactions (Murakami et al.,
2007).

Iron response in S. cerevisiae
Iron balance is critically important for the cell, because iron is on the one hand an
essential element required for the production of all proteins with an iron-sulfur
cluster, but on the other hand too much free iron is toxic. Therefore the intake of
iron is tightly regulated (Figure5-2).
It is not known how low iron is sensed, however an inhibitory signal is known to
come from the mitochondria and to be dependent on the mitochondrial transporter
Atm1 (Rutherford et al., 2005). This in turn downregulates the glutathione
reductases Grx3 and Grx4 which promote export from the nucleus of the major iron
response regulator Aft1 by forming a complex with Fra1/2 and stimulating Aft1’s
dimerization (Li et al., 2009; Pujol-Carrion et al., 2006). When Aft1 dimerizes, it is
expelled form the nucleus and thus cannot activate transcription of the iron
response genes (Ojeda et al., 2006; Yamaguchi-Iwai et al., 2002).
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Iron replete conditions:

Iron deplete conditions:

Figure 5-2 Activation of iron response in S. cerevisiae. During iron replete conditions an
unknown inhibitory signal is translocated from the mitochondrial transporter Atm1. This
stimulates Grx3 and Grx4 to induce Aft1 dimerization and subsequent export out of the
nucleus. During iron replete conditions there is no signal form the mitochondria, thus no
Grx3/4 induced Aft1 dimerization and the monomeric Aft1 remains in the nucleus and binds
to Aft1 binding site (Aft1 BS) in the promoters of genes of the iron regulon. Blue circle –
nucleus, yellow circle – vacuole, light purple oval – mitochondrion.
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When Grx3 and Grx4 are not available to bind Aft1 and facilitate its export into the
cytoplasm, the monomeric Aft1 remains in the nucleus and binds to promoters with
a specific Aft1 binding site to activate transcription. The genes activated by Aft1 are
collectively called the iron regulon.
The iron regulon includes three different classes of genes, which are further
regulated depending on the cellular responses. Activation of Aft1 leads first to
upregulation of the iron intake mechanisms; second, the cell switches, wherever
possible, to iron independent pathways; third, iron stored in the vacuole is released.
These events occur in the order listed here and if one is sufficient to overcome the
iron deficiency then the next does not take place (Philpott and Protchenko, 2008).

To determine the primary activity of the exosome I have looked at the
exonuclease and endonuclease activities independently. I used rrp44-exo- and
rrp44-endo- mutants to look at the effects they have on known exosome substrates,
growth rate, and gene expression. Additionally, in collaboration with Pamela
Green’s lab from University of Delaware, I tried to identify specific substrates of the
endonuclease. Data presented in this chapter show that the primary activity of the
exosome is the exoribonuclease and that a major consequence of inactivating the
exoribonuclease is the activation of iron response.
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RESULTS
The primary activity of Rrp44 is in the exoribonuclease
Since the exosome has both an exonuclease and an endoribonuclease, it is
unclear which activity if important for which roles of the exosome. To test which
activity is important for growth, point mutants of either the exonuclease, D551N
(rrp44-exo-), or the endonuclease, D171A (rrp44-endo-), were transformed into an
rrp44 strain and were grown for twenty four hours in liquid YPD medium. Growth
was only affected in the exonuclease but not in the endonuclease mutant indicating
that the exonuclease is important for growth under standard lab conditions (Figure
5-3).
Additionally, a deep sequencing of internally cleaved RNA fragments was
concluded with the help of Pamela Greens’ lab at the University of Delaware,
searching for products specific to the endonuclease (Figure 5-4). Parallel analysis of
RNA ends (PARE) was used to construct libraries of cleavage products of wild type
and rrp44-endo- mutant (German et al., 2009). Briefly, RNA was isolated from wild
type and rrp44-endo- and polyadenylated RNA was purified. Next, an adapter
specific to a 5’ phosphate and with a MmeI restriction enzyme binding site was
ligated to the 5’ of the RNA. The adapter ligation was followed by reverse
transcription (Figure 5-4) and then a second DNA strand was synthesized. The
resulting dsDNA was then cleaved with MmeI. MmeI one cleaves 20 bp away from
the MmeI site therefore the resulting 20 bp fragments captured the site of the
internal cleavage and 13 bp downstream.
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Figure 5-3 Growth is affected only in the exonuclease but not in the endonuclease
mutant. A growth curve representing average of three independent clones for 24 hrs
growth in liquid YPD medium. Green is wild-type, red - rrp44-exo-, and orange - rrp44-endo.
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Figure 5-4. Selection of internally cleaved products for deep sequencing. Step 1polyadenylated RNA is isolated. Cleavage products are expected to have a 5’ phosphate to
which an adaptor with MmeI recognition site is ligated. Step 2- the RNA is reverse
transcribed and PCR amplified for a second strand synthesis; Step3- Digestion with MmeI
which cuts 20bp away from its recognition site; Step 4- A 3’ adaptor is ligated to the 20bp
signature reads; Step 5- The sequences are PCR amplified and sequenced.
This figure is based on (German et al., 2009)
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Two wild-type libraries and one rrp44-endo- library were constructed. The
sequencing generated 1 282 573 20 bp unique reads that matched to the genome.
Fragments smaller than 20 bp were not detected. All identified mRNAs had less
than 5x increase in rrp44-endo- compared to wild type suggesting that the
degradation of any particular mRNA is not controlled by the endonuclease. Thirteen
candidate genes were identified based on PARE signatures that were present in the
wild-type libraries but not present in the rrp44-endo- mutant. Of these the best three
candidates were CAF20, REV1, and a dubious ORF YMR304C-A (Figure 5-5 A).
Northern blots for REV1, and YMR304C-A were unable to detect these RNAs. The
levels of the CAF20 mRNA showed no difference between wild-type and rrp44endo- on a Northern blot (Figure 5-5 B). Two tRNA genes were also a part of the
gene set of the thirteen candidates – tRNA-Asp (tRNA(GUC)L1) and tRNA-Glu
(tRNA(CUC)D). Northern blots of these two tRNAs also showed no differences in
the levels of these transcripts between wild-type and rrp44-endo- strains (Figure 5-5
C).The tRNA Asp identified in the PARE analysis is initially synthesized as a
dicistronic transcript together with tRNA Arg and then the transcript is cleaved by
RNase P which also cleaves the 5’ ends of other tRNA transcripts (Engelke et al.,
1985; Schmidt et al., 1980). Therefore Northern blots were also probed for these
two transcripts. Neither tRNA-Arg-Asp nor RNase P showed any difference in
transcript levels between wild type and rrp44-endo-. Based on these analyses it was
concluded that no specific substrates for the endonuclease activity of Rrp44 were
identified using the PARE analysis method.
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Figure 5-5 PARE analysis did not identify specific substrates for the endonuclease of
Rrp44. A. Plots of the three best candidate genes. YOR276W= CAF20, YOR346W=REV.
SCE291 (green) is the library from the rrp44-endo- strain. SCE02 (blue) and SCE290 (red)
are libraries form the wild-type strain. B. Northern blot analysis of CAF20 mRNA in wild-type
(WT) and rrp44-endo- strains. C. Northern blot analyses of tRNAGlu, tRNAAsp, RNase P,
and tRNA-Arg-Asp (polycistronic) transcripts.
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A microarray analysis of poly(A) RNA from rrp44-exo- and rrp44-endo- also did
not find any effects on gene expression for the endoribonuclease (for details on the
microarray see the sections below).
Therefore, considering that the endonuclease does not affect known exosome
roles and growth phenotype, that the deep sequencing of cleavage products failed
to identify specific endonuclease products, and a microarray failed to identify effects
on gene expression, it was concluded that the primary activity of Rrp44 is carried
out by the exonuclease.

Iron response is activated in rrp44exo- mutant
To characterize the effects the endoribonuclease or the exoribonuclease activity
of Rrp44 have on gene expression, poly(A) RNA was isolated from wild-type, rrp44exo- , and rrp44-endo- strains and hybridized to a Affymetrix S. cerevisiae / S.
pombe tiling microarray. Hybridization and initial analysis were done by the Allan
Jacobson’s Lab at the University of Massachusetts Medical School. The RNA was
isolated in quadruplicate and mRNAs that were upregulated at least two-fold were
selected for further analysis. No mRNAs were affected in the rrp44-endo- mutant,
however 84 mRNAs were upregulated and 63 were downregulated in the rrp44-exo(Table 5-1 and Table 5-2)

To assess if there was enrichment of any particular cellular processes, a gene
ontology (GO) analysis was used. The main GO terms that were identified were all
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related to iron uptake. Altogether, 10 of the 84 mRNAs (12%) were directly
implicated in iron uptake. To verify the microarray results, a Northern blot was
completed with FIT2 and TIS11 probes (Figure 5-6). In addition, RNA was isolated
from an independently created rrp44-exo- mutant and the same RNAs was analyzed
by a Northern blot. Increase in FIT2 and TIS11 mRNAs was noted in both the
original and the independently created strain, thus it was concluded that the
upregulation of iron response is a major physiological response in rrp44-exo-.

Iron response in the rrp44-exo- is activated by activation of Aft1
Since a mutant that is defective specifically in RNA degradation (rrp44-exo-) was
used for the microarray, there were two possibilities for the increased abundance of
the iron regulon mRNAs. First, the exonuclease could be degrading these mRNAs
which would lead to their increase in an exonuclease mutant. Second, the increase
may be secondary to some other effect caused by the exonuclease which leads to
activation of the transcription factor responsible for activating transcription of these
mRNAs. Aft1 is the transcription factor that is the major factor responsible for
regulating iron response. Aft1 has been shown to bind to a ANTGCACCC elements
in promoters of Aft1-regulated genes and stimulate transcription (Yamaguchi-Iwai et
al., 1996).
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Table 5-1 Microarray data – genes upregulated at least twofold in all four samples
Gene

FIT2

FIT3

Fold
elevation

Synonym

Description

9.61

YDR042C

ORF, Uncharacterized

8.47

YKL183C-A

ORF, Uncharacterized

YOR382W

siderophore-iron transporter

6.78

YHR022C-A

ORF, Uncharacterized

5.93

YHR214C-E

ORF, Uncharacterized

5.73

YGR121W-A

ORF, Uncharacterized

YOR383C

Siderophore-iron transporter

YAR075W

Nonfunctional protein

YLR136C

7.73

5.51

Aft1
BS

yes

yes

5.50
TIS11

5.47

ECM12

5.25

YHR021W-A

mRNA-binding protein expressed during iron
starvation
ORF, Uncharacterized

PRM6

5.07

YML047C

Pheromone-regulated protein

4.74

YML007C-A

ORF, Uncharacterized

YEL065W

Transporter of siderophore-iron chelates

4.26

YBR298C-A

ORF, Uncharacterized

4.13

YAL064W

Protein of unknown function

4.09

YOR394C-A

ORF, Uncharacterized

3.98

YBR040W

3.98

YOL155W-A

Integral membrane protein required for efficient
mating
ORF, Uncharacterized

3.89

YMR001C-A

ORF, Uncharacterized

AGA2

3.88

YGL032C

Adhesion subunit of a-agglutinin of a-cells

DIP5

3.88

YPL265W

Dicarboxylic amino acid permease

GRE1

3.87

YPL223C

Stress induced hydrophillin

3.86

YOL097W-A

ORF, Uncharacterized

3.82

YHR214C-D

ORF, Uncharacterized

YHL040C

Transporter of siderophore-iron chelates

YLL066W-B

ORF, Uncharacterized

YLR205C

ER localized, heme-binding peroxidase

SIT1

FIG1

ARN1

4.73

3.79

yes

yes

yes

3.72
HMX1

3.69

NRD1

3.67

YNL251C

nuclear RNA-binding protein

3.59

YBR296C-A

ORF, Uncharacterized

3.57

YGR204C-A

ORF, Uncharacterized

SET6

3.46

YPL165C

Protein of unknown function

ARP10

3.39

YDR106W

Component of the dynactin complex

3.37

YOL162W

ORF, Uncharacterized

3.29

YPR002W

3.29

YOR032W-A

Mitochondrial protein that participates in
respiration, induced by diauxic shift
ORF, Uncharacterized

3.24

YNL277W-A

ORF, Uncharacterized

PDH1

yes
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Table 5-1 ( continued) Microarray data – genes upregulated at least twofold in all four
samples
Gene

Synonym

Description

3.21

YIL117C

Pheromone-regulated protein

3.17

YCR108C

ORF, Uncharacterized

HUG1

3.16

YML058W-A

VMR1

3.13

YHL035C

Protein involved in the Mec1p-mediated
checkpoint pathway
Vacuolar membrane protein

3.11

YGR035C

ORF, Uncharacterized

MAL33

3.09

YBR297W

MAL-activator protein

ARN2

3.09

yes

YHL047C

Transporter of siderophore-iron chelates

FRE2

3.07

yes

YKL220C

Ferric and cupric reductase

PRM2

3.05

YIL037C

Pheromone-regulated protein

CUE2

3.05

YKL090W

Protein of unknown function

TAD2

3.02

YJL035C

IMD1 ;
IMD2
HES1

3.00

YAR073W

2.98

YOR237W

TIR4

2.96

YOR009W

Subunit of tRNA-specific adenosine-34
deaminase
Nonfunctional protein with homology to IMP
dehydrogenase
Protein implicated in the regulation of ergosterol
biosynthesis
Cell wall mannoprotein

ALP1

2.94

YNL270C

Basic amino acid transporter

NCA3

2.92

YJL116C

Protein involved in mitochondrial organization

PRM5

Fold
elevation

Aft
1
BS

2.92

YOL163W

ORF, Uncharacterized

COS12

2.87

YGL263W

Protein of unknown function

MIG2

2.87

YGL209W

Zinc finger transcriptional repressor

2.81

YER078W-A

ORF, Uncharacterized

CIN1

2.77

YOR349W

Tubulin folding factor D

RKM5

2.76

YLR137W

Protein lysine methyltransferase

FUS2

2.74

YMR232W

Cytoplasmic protein localized to the shmoo tip

FYV5

2.72

YCL058C

MND1

2.71

YGL183C

2.69

YLR108C

Protein involved in regulation of the mating
pathway
Protein required for recombination and meiotic
nuclear division
Protein on unknown function

AYT1

2.68

YLL063C

Acetyltransferase

FLO1

2.67

YAR050W

Lectin-like protein involved in flocculation

ZPS1

2.67

YOL154W

Putative GPI-anchored protein

2.65

YOL114C

ORF, Uncharacterized

YMR058W

Ferro-O2-oxidoreductase
Protein involved in regulation of arginineresponsive and Mcm1p-dependent genes
ORF, Uncharacterized

FET3

2.60

yes

ARG82

2.57

YDR173C

2.56

YNL024C
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Table 5-1 ( continued) Microarray data – genes upregulated at least twofold in all four
samples
Gene

Fold
elevation

Aft
1
BS

Synonym

Description

2.52

YLR412C-A

ORF, Uncharacterized

2.48

YJL136W-A

ORF, Uncharacterized

MIG3

2.46

YER028C

ENB1

2.45

Transcriptional regulator; role in catabolite
repression and ethanol response
Endosomal ferric enterobactin transporter

RRN3

2.44

YKL125W

2.44

YJL027C

Protein required for transcription of rDNA by RNA
polymerase I
ORF, Uncharacterized

2.40

YGR146C-A

ORF, Uncharacterized

CCC2

2.39

YDR270W

Cu(+2)-transporting P-type ATPase

DAN3

2.30

YBR301W

Cell wall mannoprotein

2.30

YIL089W

Protein of unknown function

MTC3

2.27

YGL226W

Protein of unknown function

PCK1

2.26

YKR097W

Phosphoenolpyruvate carboxykinase

AIM4

2.12

YBR194W

Protein proposed to be associated with the
nuclear pore complex

yes

YOL158C
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Table 5-2 Microarray data- genes downregulated at least twofold in all four samples

Gene

Fold
elevation
0.05

Synonym

Description

YDR380W

Phenylpyruvate decarboxylase

GYP5

0.06

YPL249C

ARO9

0.16

YHR137W

GTPase-activating protein (GAP) for yeast Rab family
members, involved in ER to Golgi trafficking
Aromatic aminotransferase

INH1

0.17

YDL181W

GRX4

0.18

YER174C

Protein that inhibits ATP hydrolysis by the F1F0-ATP
synthase
Monothiol glutaredoxin

MGA1

0.20

YGR249W

Protein similar to heat shock transcription factor

PHM6

0.22

YDR281C

Protein of unknown function

HFM1

0.25

YGL251C

Meiosis specific DNA helicase

YFH7

0.25

YFR007W

Putative kinase

SPO1

0.26

YNL012W

Meiosis-specific protein

LIN1

0.26

YHR156C

Non-essential component of U5 snRNP

HXT7 ;
HXT6
ISF1

0.26

YDR342C

High-affinity glucose transporter

0.27

YMR081C

Serine-rich, hydrophilic protein

PHO89

0.27

YBR296C

Na+/Pi cotransporter, active in early growth phase

NRT1

0.27

YOR071C

High-affinity nicotinamide riboside transporter

SPL2

0.28

YHR136C

Protein with similarity to cyclin-dependent kinase inhibitors

ARO10

0.28

YNL040W

ORF, Uncharacterized

GMC1

0.29

YDR506C

Protein involved in meiotic progression

PHO5

0.30

YBR093C

Repressible acid phosphatase

FMP48

0.30

YGR052W

ORF, Uncharacterized

CYB2

0.31

YML054C

Cytochrome b2

LAP4

0.31

YKL103C

Vacuolar aminopeptidase

TIR1

0.31

YER011W

COX4

0.31

YGL187C

Cell wall mannoprotein , expression is downregulated at
acidic pH
Subunit IV of cytochrome c oxidase

0.31

YKL151C

NADHX dehydratase

DDR48

0.33

YMR173W

DNA damage-responsive protein

TAX4

0.34

YJL083W

TPO4

0.34

YOR273C

Protein involved in regulation of phosphatidylinositol 4,5bisphosphate concentrations
Polyamine transport protein

0.34

YPL113C

Glyoxylate reductase

0.34

YCL025C

0.34

YNL134C

Low-affinity amino acid permease,, involved in uptake of
asparagine, glutamine, and other amino acids
Protein of unknown function

EDS1

0.34

YBR033W

ORF, Uncharacterized

TIR3

0.35

YIL011W

Cell wall mannoprotein

0.35

YHR202W

ORF, Uncharacterized

AGP1
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Table 5-2 (continued) Microarray data- genes downregulated at least twofold in all four
samples
Gene
Gene
Gene
Gene
CYT1

0.36

YOR065W

Cytochrome c1

HSP30

0.36

YCR021C

Hydrophobic plasma membrane protein

GDH1

0.37

YOR375C

NADP(+)-dependent glutamate dehydrogenase

CYC1

0.38

YJR048W

Cytochrome c, isoform 1

ARG1

0.38

YOL058W

Arginosuccinate synthetase

GGC1

0.38

YDL198C

Mitochondrial GTP/GDP transporter

CUE5

0.38

YOR042W

Protein containing a CUE domain that binds ubiquitin

ALD5

0.38

YER073W

Mitochondrial aldehyde dehydrogenase

RTC3

0.38

YHR087W

Protein involved in RNA metabolism

ARG3

0.39

YJL088W

Ornithine carbamoyltransferase

VTC3

0.39

YPL019C

Vacuolar membrane protein

GPH1

0.39

YPR160W

GAD1

0.40

YMR250W

Glycogen phosphorylase required for the mobilization of
glycogen
Glutamate decarboxylase

CSR2

0.40

YPR030W

PHO11 ;
PHO12

0.40

YAR071W

0.40

YPL014W

Nuclear protein with a potential regulatory role in utilization of
galactose and nonfermentable carbon sources
One of three repressible acid phosphatases, a glycoprotein
that is transported to the cell surface
ORF, Uncharacterized

GSY1

0.41

YFR015C

Glycogen synthase

WSC4

0.41

YHL028W

ER membrane protein

RIP1

0.42

YEL024W

ARG5,6

0.42

YER069W

0.42

YJR129C

Ubiquinol-cytochrome-c reductase, a Rieske iron-sulfur
protein of the mitochondrial cytochrome bc1 complex
Protein that is processed in the mitochondrion to yield
acetylglutamate kinase and N-acetyl-gamma-glutamylphosphate reductase, which catalyze the 2nd and 3rd steps
in arginine biosynthesis
ORF, Uncharacterized

TFB6

0.42

YOR352W

Subunit of TFIIH complex

CPA2

0.43

YJR109C

Large subunit of carbamoyl phosphate synthetase

RIP1

0.43

MNN1

0.44

AFFX-r2-ScRIP1-M
YER001W

Ubiquinol-cytochrome-c reductase, a Rieske iron-sulfur
protein
Integral membrane glycoprotein of the Golgi complex

HXT4

0.44

YHR092C

COR1

0.45

YBL045C

MEP1

0.45

YGR121C

High-affinity glucose transporter of the major facilitator
superfamily
Core subunit of the ubiquinol-cytochrome c reductase
complex (bc1 complex)
Ammonium permease

SMF1

0.46

YOL122C

Divalent metal ion transporter
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Figure 5-6 Verification of microarray results. A Northern blot with probes for FIT2 and
TIS11 in wild-type (WT) and rrp44-exo-. The numbers in parenthesis indicated the fold
elevation in the microarray. SRP is the RNA part of the signal recognition particle, used for
loading control.
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Each of the iron response genes that were upregulated in the microarray had a
binding site for Aft1 in its promoter region. These data suggested that rrp44-exomay cause Aft1 activation, which in turn would increase the transcription of the iron
response mRNAs.
To test whether Aft1 was activated, two assays were conducted. First, an indirect
lacZ based assay was completed. Briefly, a lacZ reporter gene with a minimal CYC1
promoter and an Aft1 binding site was constructed. As a control, the same vector,
but without the Aft1 site was used. The reporter plasmids were transformed into
wild-type and rrp44-exo- strains and a beta-galactosidase activity assay was carried
out. Beta-galactosidase levels were increased 2.1 fold in the rrp44-exo- strain
compared to the wild-type strain (Figure 5-7 A). In addition, when comparing only
the levels of the control reporter, without the Aft1 binding site, in wild type versus
rrp44-exo-, these levels were not significantly different (Figure 5-7 B). This indicates
that rrp44-exo- does not affect the level of the reporter itself. To directly observe
Aft1 localization a construct with GFP-tagged Aft1 was transformed into an rrp44exo- strain and in wild-type strain. Aft1 was observed to be localized in the nucleus
in 44% of the cells, while only in 15% of the wild-type cells, which is consistent with
it being activated in the rrp44-exo- mutant (Figure 5-8).
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A

n=3

B

n=3

Figure 5-7 Aft1 is activated in rrp44-exo-. A. Beta-galactosidase activity of wild-type and
rrp44-exo- transformed with a reporter with either Aft1 binding site or without (vector). The
data is averaged of 3 experiments and normalized to wild-type. B. A close-up views of the
wild-type versus rrp44-exo- transformed with only the reporter. This is the same data as
above, but normalized to the wild-type + vector strain.
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Taken together these data suggest that the increased levels of iron regulon
mRNAs was not directly caused by the exonuclease by means of these mRNAs not
being degraded, but due to activation of Aft1. Therefore the exonuclease indirectly
affects the activation of iron response in S. cerevisiae.

The iron response activation in rrp44-exo- is not due to aberrant ATM1
expression
The inhibitory signal for the activation of iron response is known to be dependent
of the mitochondrial transporter Atm1.To test whether Atm1’s expression was
affected in the rrp44-exo- mutant, a Northern blot was completed with probe for
ATM1. ATM1 was not affected in the microarray and as seen in Figure 5-9 there
were no differences in the expression of ATM1 in wild type and the rrp44-exomutant. This suggests that the improper iron activation is not due to an aberrant
mitochondrial signaling event. One of the regulators of Aft1, Grx4, was one of the
downregulated mRNAs in the microarray; however numerous attempts to detect
GRX4 by Northern blots or RT PCR failed, thus the microarray down regulation
could not be verified.
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Figure 5-8. Aft1 localizes to the nucleus in higher percentage of rrp44-exo- cells than
in wild-type cells. Fluorescent microscopy of wild-type and rrp44-exo- cells transformed
with Aft1-GFP reporter.
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Figure 5-9. The levels of ATM1 are the same in wild type and rrp44-exo-. Northern blot
with probes for ATM1 and SRP (loading control) in wild-type (WT) and rrp44-exo-.
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DISCUSSION

This chapter examines the importance of the different ribonuclease domains of
Rrp44 and their effect on gene expression. I have shown that the primary activity of
Rrp44 is in the exoribonuclease domain. In addition I have determined that a major
consequence of the exonuclease inactivation is the indirect activation of iron
response.
Interestingly, I was unable to find any specific substrates for the endonuclease
and there was no effect of gene expression in the rrp44-endo- mutant as determined
by the microarray analysis. These data are consistent with the data that rrp44-endoalso does not have a growth phenotype and with other studies that also were
unable to find substrates for the endonuclease (Schneider et al., 2012). However,
knockouts of the endonuclease and exonuclease of Rrp44 are synthetically lethal.
Therefore for the essential role of Rrrp44, the endonuclease overlaps with the
exonuclease. The data presented here suggest that all of the endonuclease
substrates are also substrates for the exonuclease, while the opposite is not true. It
is possible that for the most critical substrates, the ones that cause the synthetic
lethality phenotype, the exosome has developed a back-up system by using two
separate active sites to ensure their degradation or processing. It would be
interesting to find out what the effect on gene expression is in a knock-out of both
enzymatic activities on Rrp44. However, since a double mutant is inviable such an
experiment inherently has certain limitations. For example, it can only be done
shortly after knocking out both enzymatic activities possibly not giving it enough
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time for major changes to occur. Yet, it would be interesting to determine if new
substrates, not affected in the single mutant, emerge from such a screen.

Activation of iron response seems to be a major consequence of the inactivation
of the exonuclease. Therefore, in the wild-type strain, the exonuclease actually
functions as a negative regulator of iron response. Iron response is a very
complicated process which includes various control points. For example, if iron is
low, iron importers are upregulated and iron is imported into the cell. However, if the
influx of iron is still not sufficient, then a reorganization of metabolic processes take
place to include enzymes that are iron independent and if the influx of iron is
sufficient then this metabolic reorganization does not occur. Yet another check point
exists, in the case when the influx of iron and the metabolic reorganization are still
not sufficient, the iron stored in the cellular vacuole is released. Therefore even
when the major regulator of iron response Aft1 is activated, there are more
checkpoints downstream of it to ensure the correct response is carried out. The
exonuclease of Rrp44 seems to function on the initial response to iron deprivation,
because neither genes for metabolic reorganization, nor vacuolar genes involved in
iron response were affected in rrp44-exo-.
Two of the three total functional studies of Rrp44 have found a connection
between microtubules and Rrp44 (Murakami et al., 2007; Smith et al., 2011). Here, I
find that the major transcription factor of iron response is activated in rrp44-exo-.
Interestingly, Aft1 was recently found to interact with kinetochore proteins (Hamza
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and Baetz, 2012). It would be interesting to find out if a connection between these
two phenotypes, Aft1 activation and kinetochore-microtubule defects, exists.
It was surprising to find out that the effect on gene expression was relatively
modest, with 84 upregulated and 63 downregulated mRNAs. Since the exosome is
an exoribonuclease, the downregulated mRNAs were certainly indirectly affected
and in addition I determined that for at least the 10 iron response mRNAs, the effect
was also indirect. The fact that there is so much indirect effect can be explained by
the fact that the essential role of Rrp44 is in the nucleus, while in the cytoplasm the
role of the exosome in mRNA degradation overlaps with that of the enzymes from
the 5’3’ mRNA degradation pathway. Therefore, any effect on gene expression
that is exosome specific is more likely to be affected by the nuclear exosome, thus
most likely to be indirect.
Another cytoplasmic role for the exosome is the degradation of aberrant nonstop
mRNAs. This role is independent of the 53’ degradation pathway, thus it is
exosome specific. However, it is not likely that the mRNAs seen in the microarray
are the results of lack of nonstop mRNA degradation, because for that role the
exonuclease and the endonuclease were shown to be redundant (Schaeffer and
van Hoof, 2011). In the strains used for the microarray, rrp44-exo- and rrp44-endo-,
there is always either exonuclease or endonuclease activity of Rrp44 which would
rapidly degrade such mRNAs therefore they would not be detected by the
microarray.
Again, as with the lack of identified substrates for the endonuclease, one possible
explanation for the modest effect on gene expression is the possible overlap of
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degradation or processing roles between the exonuclease and the endonuclease for
the most critically important substrates. The nucleus is the location where the
exosome’s role is essential. In human cells only the Rrp44 homologue that localizes
to the nucleus has retained an endonuclease activity (Tomecki et al., 2010). This is
consistent with the idea that the two activities may overlap for the most critical
substrates.
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Chapter 6: The exoribonuclease of Rrp44 affects glucose fermentation and
production of reactive oxygen species
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INTRODUCTION
Iron metabolism and oxidative stress in S. cerevisiae
Iron is an essential element needed for the activity of many enzymes. Due to the
high reduction potential of the Fe3+/Fe2+ pair, iron is a part of several proteins in
the electron transport chain (ETC). In the ETC iron is found as a part of iron-sulfur
proteins where it is a part of iron-sulfur clusters. It is also found in cytochromes,
where it is contained in their heme groups. The purpose of the ETC is to build
proton gradient to be used as energy for the ATP synthase (for a detailed review of
the ECT in yeast, refer to de Vries and Marres, 1987; Schagger, 2002). Oxidation of
NADH and FADH2 however requires the initial transfer of protons together with
electrons. As H2 atoms are transported across the membrane they are oxidized and
H+ is pumped across the membrane, while electrons are shuttled via the rest of the
ETC to the terminal electron acceptor, in this case oxygen (Becker et al., 2003). Iron
in the iron-sulfur clusters receives electrons one at a time, as the protons are
pumped through the membrane (Becker, Kleinsmith et al. 2003). Therefore iron is a
critical element for the establishment of proton gradient in the mitochondrial
intermembrane space and consequently for the cellular ability to produce ATP
(Figure 6-1).
However, as essential as iron is for respiration, it is also important to be kept in
balance. If iron is in excess and is not sequestered either in the vacuole or as a part
of a protein, free iron can cause the formation of reactive oxygen species (ROS).
ROS are constantly produced during normal cellular processes and are also

125

Figure6-1. The electron transport chain (ETC) of S. cerevisiae. S. cerevisiae does not
have complex I, instead NADH from the TCA cycle is oxidized by the NADH oxidases Nde1
and Nde2. FADH2 from the TCA cycle is oxidized by Complex II. The NADH oxidases and
complex II each transfer electrons to Ubiquinone(Ub), a mobile electron carrier, which in
turn transfers them to the bc1 complex (also called complex III). From the bc1 complex,
electrons are transferred to another shuttle molecule. Cytochrome C. Cytochrome C
shuttles the electrons to Cytochrome C oxidase (COX) also called complex 4, which in turn
transfers them to the terminal electron acceptor oxygen. As electrons are transferred,
protons are pumped through the inner mitochondrial membrane into the intermembrane
space and the proton gradient that is created is used by the ATP synthase to make ATP
from ADP and inorganic phosphate. The two places where electrons leak from the ETC are
at the Nde1/2 and the bc1 complex. If excess free iron is available, reactive oxygen species
(ROS) are formed.
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constantly detoxified. Damage caused by ROS is also constantly repaired, and in
the event of oxidative stress, the cell responds by a series of events collectively
called the oxidative stress response.

Location and timing of production of ROS in S. cerevisiae
The mitochondrial membrane is the main location of ROS production. This is due
to electrons escaping the ETC during respiration and reacting with other molecules
(Murphy, 2009). However, S. cerevisiae, when grown on glucose (or any
fermentable sugar) as a carbon source, grows preferentially by fermentation,
thereby shutting off respiration and producing ethanol which is excreted outside of
the cell. When glucose is no longer available, S. cerevisiae switches to respiration
and oxidizes the remaining non-fermentable carbon source. The process of
switching to respiration is accompanied by a major change in transcription and
slowing down of growth rate and it is referred to as a diauxic shift. (Figure 6-2)
(Zaman et al., 2008). Respiratory metabolism requires the use of the ETC, thus
more ROS are produced, but also more oxidative stress responses are upregulated
to neutralize the effect of these ROS.

Detoxification of ROS
Detoxification of ROS is mainly accomplished enzymatically via detoxifying
enzymes. The major ROS detoxifying enzymes are superoxide dismutases
(SODs), catalases, and peroxidases (Herrero et al., 2008). These enzymes are
upregulated upon oxidative stress to detoxify the produced ROS.
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Figure 6-2. Depiction of the two growth phases of S. cerevisiae when using glucose
as carbon source. During the first phase (yellow shaded area) S. cerevisiae grows by
fermenting the glucose in the medium and excreting ethanol. As glucose is used up a
metabolic change, referred to as the diauxic shift occurs. Growth rate slows and S.
cerevisiae reorganizes it metabolism to utilize the ethanol in the medium by respiration
(pink shaded area).

128

Oxidative damage repair
Oxidative stress causes damage in virtually all cellular molecules, including DNA,
RNA, proteins, and lipids. Sulfhydryl groups of proteins are especially vulnerable to
oxidative damage. S. cerevisiae has two major systems to repair protein damage
from oxidation, the thioredoxin (TRX) and the glutaredoxin (GRX) systems, as well
as other reductases. Both the TRX and the GRX systems use small molecules
which contain cysteine. When a protein is oxidized, the thioredoxins or the
glutaredoxins reduce it by oxidizing their own cysteines. Both systems are
complemented by reductases which in turn reduce the thioredoxins or the
glutaredoxins to recycle them (Grant, 2001).

Regulation of oxidative stress response
Oxidative stress responses are regulated at the transcriptional level by the
transcription factors Yap1 and Skn7 (Brown et al., 1993; Hirata et al., 1994; Krems
et al., 1996). Yap1 is involved in transcriptional control of all thioredoxin and
glutathione dependent system as well as the pentose phosphate pathway (PPP).
The PPP’s activation is needed in order to provide reducing equivalents for both
systems. Skn7 is only required for activation of some but not all proteins of the TRX
system.

Chapter 5 showed that iron response is activated indirectly in the rrp44-exomutant. Experiments presented in this chapter were conducted to investigate the
cause of this activation. Data presented in this chapter shows that ROS levels are
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elevated in rrp44-exo- mutant and that the ROS elevation is functionally related to
iron response activation. Further, I show that the exoribonuclease mutation causes
aberrant glucose fermentation.
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RESULTS

The exonuclease is required for protection from hydrogen peroxide induced
oxidative stress
As excess iron can lead to increased production of ROS, the sensitivity of the
rrp44-exo- mutant to oxidative stress was tested. rrp44-exo- was grown both in
liquid YPD medium supplemented with 2hydrogen peroxide (H2O2; Figure 6-3
A) or on solid YPD medium (Figure 6-3B) supplemented with 2H2O2. In both
cases the rrp44-exo- mutant did not grow while the wild-type control grew, indicating
that rrp44-exo- is hypersensitive to oxidative stress.
To test if the sensitivity was specific to hydrogen peroxide or if other oxidative
stressor could cause similar sensitivity, rrp44-exo- was grown on medium
supplemented with 50menadione which is another oxidative stress agent. The
difference between menadione and H2O2 is that menadione does not cause an
increase of H2O2 but an increase of superoxide (Goldberg and Stern, 1976). Growth
on medium with menadione was not affected compared to growth on YPD (Figure
6-4A) indicating that the hypersensitivity was specific to H2O2.
To test if the knockout of the exonuclease caused sensitivity to other general
stressors, rrp44-exo- strain was also grown at high temperature, 37oC and low
temperature, 15oC (Figure 6-4 B). There was no effect on growth compared to
growth on YPD at 30oC. These data indicated that rrp44-exo- was not generally
sensitive to stress. Taken together, I concluded that rrp44-exo- is hypersensitive to
hydrogen peroxide induced oxidative stress.
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Figure 6-3. rrp44-exo- is hypersensitive to hydrogen peroxide. A. rrp44-exo- and wildtype (WT) S. cerevisiae strain were grown in liquid YPD versus YPD+2H2O2 cultures.
Dashed lines represent growth in YPD; solid lines represent growth in YPD+2MH2O2.
Green - wild-type; red - rrp44-exo-. B. Growth assay on wild-type and rrp44-exo- on solid
medium with and without 2 M H2O2.
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Figure 6-4. rrp44-exo- is not hypersensitive to menadione or temperature stress. A.
Plate growth assay of wild-type and rrp44-exo- on YPD+ 50menadione and on YPD. B.
Growth assay on YPD at the indicated temperatures.
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The exonuclease mutant has increased intracellular levels of ROS

Either higher production of ROS or the inability to detoxify normal ROS levels can
lead to the observed H2O2 hypersensitivity phenotype. To test if rrp44-exo- has
increased ROS levels, an ROS detection assay was carried out. Briefly, wild-type
and rrp44-exo- cells were grown in YPD and in YPD + 1H2O2. Next, H2DCFDA
(2',7'-dichlorodihydrofluorescein diacetate) reagent was added and fluorescence,
indirectly indicating ROS levels, was measured in a plate reader (for details of the
assay see Chapter 2). During growth in YPD medium rrp44-exo- had 2x elevated
ROS levels relative to wild-type and in YPD+1H2O2 the rrp44-exo- had 2.3x
elevated ROS levels over the wild-type strain (Figure6-5).
As mentioned earlier, either increased production or defective detoxification can
lead to increased levels of ROS. However, the microarray data did not point to any
enzymes normally involved in ROS detoxification. These data, and the results from
the ROS detection assay above, suggest that the exonuclease mutant has
increased production of ROS.

Altered iron response and sensitivity to oxidative stress in the rrp44-exomutant are functionally connected.
Many factors affect if iron response is activated. It is possible that the iron
response activation in rrp44-exo- is related to the ROS production or it is possible
that the activated iron response is independent of the ROS production. To test that,
I added iron to oxidatively stressed cells and monitored growth rate.
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Figure 6-5. rrp44-exo- has increased ROS levels. Relative ROS levels were measured in
wild-type( green) and rrp44-exo- ( red) with and without H2O2 treatment as indicated. n=3
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If growth rate is improved, that would indicate that the iron response and oxidative
stress are functionally related in rrp4-exo- because it would mean that iron response
itself is not misregulated, but it rather a consequence of oxidative stress. If however
there was increased sensitivity or no change, then this would indicate that these two
processes are affected by the exonuclease independently of each other.
Wild-type and rrp44-exo- cells were stressed with 1H2O2 for one hour and
then 100Ferrous Ammonium Sulfate (FAS) was added to the medium as a
source of Fe3+. Figure 6-6A shows that addition of FAS improved the growth rate of
rrp44-exo- but did not affect the wild-type strain. This improvement in growth was
specific to oxidatively stressed cells as addition of FAS to cells grown in YPD
without H2O2 did not have any effect on growth rate (Figure 6-6B).
Growth on solid medium supplemented with 1000x Fe and with low iron was not
affected in rrp44-exo- compared to growth on SC (Figure 6-6C). In this case SC
medium was chosen over YPD because SC medium has defined amounts of
nutrient including iron, therefore making it possible for exact iron calculations to be
conducted for the 1000x medium.
To further support the hypothesis the rrp44-exo- has higher requirements for iron,
instead of a misregulated iron response, a Northern blot was conducted with a
probe against FIT2. Both wild type and rrp44-exo- were grown either on YPD, or on
increasing concentrations of H2O2 – 0.5 M H2O2 and 1.0 M H2O2. As shown
earlier, rrp44-exo- upregulates the iron regulon without additional oxidative stress.
However both wild type and rrp44-exo- upregulate iron response upon oxidative
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Figure 6-6. Iron response and oxidative stress are functionally related in rrp44-exo-.
A Growth of wild type and rrp44-exo- in YPD stressed with H2O2 for one hour (dashed lines)
or stressed with H2O2 for one hour followed by supplementation by 100Fe (solid lines).
B. Growth of wild-type and rrp44-exo- - in YPD (dashed lines) or YPD+ 100Fe (solid
lines). C. Growth assay of wild type and rrp44-exo- on synthetic complete (SC) medium with
addition of 1000xFe or without iron.
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stress indicating the upregulation of iron response is a normal physiological
response of the cells during stress with H2O2 (Figure 6-7).

The exonuclease of the exosome affects the cellular growth during
fermentative conditions, but not during respiratory conditions
In wild-type cells, oxidative stress is produced mostly during respiration. However
S. cerevisiae grown in log phase on YPD medium grows by fermentation until all of
the glucose is used up and then it switches to respiration, during which it uses up
the ethanol that has been excreted in the medium during the fermentative growth
phase (Zaman et al., 2008). To compare growth rates during respiratory conditions,
wild-type strain and rrp44-exo- mutant were grown in YEP + 2% glycerol medium.
This medium has glycerol instead of glucose as a sole carbon source. Since
glycerol in a non-fermentable carbon source, growth on this medium forces S.
cerevisiae to grow by respiration. Interestingly, during respiratory growth on YEP+
glycerol, wild-type cells and rrp44-exo- growth was the same (Figure 6-8A). The
results were specific to respiratory growth, not only to glycerol, because wild-type
and rrp44-exo- grew with the same phenotype on medium supplemented with
ethanol (YEP+ 2% ethanol) also. The similar growth rates were also confirmed with
growth in liquid YEP+ glycerol medium (Figure 6-8B). Based on the above data I
concluded that rrp44-exo- affects only fermentative growth rate but not the
respiratory growth.
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Figure 6-7. Activation of iron response after oxidative stress. Northern blots probed for
FIT2 of wild-type and rrp44-exo- treated with increasing amounts of H2O2, as indicated.
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A

B

Figure 6-8. rrp44-exo- does not have severe growth defect compared to wild-type
during respiratory growth. A. Wild type and rrp44-exo- growth assay on YEP medium
supplemented with 2% glucose, 2% glycerol, or 2% ethanol. B. Growth assay of wild type
and rrp44-exo- in liquid YEP+ glycerol medium.
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Slow growth phenotype of rrp44-exo- correlates with increased ROS levels
If the increased ROS causes the slow growth phenotype, then it is expected that
there will be no increase in ROS compared to wild type under conditions when the
rrp44-exo- grows with the same rate as wild type. The only such known condition is
respiratory growth. To check the ROS levels during respiratory growth, the ROS
detection assay with H2DCFDA was repeated after growing the cells in YEP +
glycerol. The ROS levels in wild-type and rrp44-exo- cells had no significant
difference (Figure 6-9). This indicated that ROS increase is a possible explanation
for the slow growth phenotype of the rrp44-exo- mutant.

RNA processing and degradation defects of rrp44-exo- are independent of its
slow growth phenotype and do not correlate with increase of ROS
Another possible explanation of the slow-growth phenotype is that it is caused by
defects in processing and degradation of stable RNAs such as rRNA and snRNA
that are known substrates for the exonuclease. To test if the defects in the
transcripts were still present during respiratory growth, Northern blots were done
with RNA isolated from cells grown in YEP + glycerol and probes against 5.8S
rRNA, 5’ETS, and U4 snRNA. None of the defects present in YPD growth
disappeared upon growth in YEP + glycerol (Figure 6-10). These data indicate that
processing and degradation defects of rrp44-exo- are independent of its slow growth
phenotype and does not correlate with increase of ROS.
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Figure 6-9. During respiratory growth rrp44-exo- and wild type have the same ROS
levels. Relative ROS levels were measured in wild type (green) and rrp44-exo- (red) grown
in YEP+ 2% glycerol medium.
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Figure 6-10. Processing and degradation defects of rrp44-exo- are independent of its
slow growth. Northern blot analyses of wild type and rrp44-exo- grown either by
fermentation (glucose) or respiration (glycerol). The blots were probed for A. 5.8S rRNA B.
5’ETS, and C. U4 snRNA.
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rrp44-exo- causes aberrant glucose metabolism

The fact that rrp44-exo- grows at a different rate compared to wild type during
respiratory and fermentative conditions suggests that there is an aberrancy
occurring during fermentative growth. One possibility is that rrp44-exo- prematurely
activates the ETC, going into respiration before all of the glucose is used up.
Another possibility is that rrp44-exo- produces different metabolites during glucose
fermentation than the wild type.
To test if the ETC was prematurely activated, Northern blots with probes against
components of the bc1 complex (complex III) were conducted. The bc1 complex
has also been postulated to be the site of most oxidative stress production (Drose
and Brandt, 2008). None of the components of the bc1 complex were upregulated
(Figure 6-11) and one, Rip1, which is an iron sulfur protein, had lower levels, both in
fermentative (with glucose as a carbon source) and respiratory (with glycerol as a
carbon source) conditions. This indicates that the rrp44-exo- does not upregulate
ETC genes.
To further test if there is aberrancy with the glucose metabolism, the glucose
intake, the ethanol output, and growth were measured over twenty four hour period
of growth in YPD. Both wild-type cells and rrp44-exo- used the same amount of
glucose when corrected for growth rate, however rrp44-exo- had lower ethanol
output (Figure 6-12). Glucose metabolism in S. cerevisiae produces ethanol, but it
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Figure 6-11. Levels of ETC transcripts are not upregulated in rrp44-exo-. Northern blot
analyses of wild type and rrp44-exo- grown either by fermentation (glucose) or respiration
(glycerol). The probe is indicated on the right of each blot. Relative levels compared to SRP
are shown below each blot.
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Figure 6-12. Glucose metabolism is aberrant in rrp44-exo-. Wild-type and rrp44-exowere grown in YPD over 24hr period in triplicates. A. Percentage of glucose in the medium.
B. Percentage of ethanol in the medium. C. pH of the medium in which wild type and rrp44exo- strains were grown was measured at the indicated OD600,
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also produces lactic acid and acetic acid. The production of lactic or acetic acid will
lower the pH of the medium. To test if either of these two metabolites may be
produced, the pH of the medium was measured. Interestingly, it was found that the
pH of the rrp44-exo- is 2 points lower, at 5, than the starting pH of 7 indicating
acidification of the medium. While the medium of the wild type strain i salso initially
acidified, it is recovered and goes back to neutral pH=7 again during the respiratory
growth. All of the above data indicate that glucose metabolism is aberrant in rrp44exo- with lower production of ethanol and higher production of acidic metabolites,
possibly lactate, acetate, or both.
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DISCUSSION

The data presented in this chapter show the physiological importance of the
exonuclease of Rrp44 during major cellular processes such as generation of
oxidative stress and glucose metabolism.
The fact that addition of iron to oxidatively stressed cells improves the growth rate
in the rrp44-exo- mutant, shows that the observed activation of iron response is not
in fact a misregulation of the iron response itself. Instead, the iron response
activation is a physiological consequence of another currently unknown aberrancy
resulting from the lack of the exonuclease activity. Increase of ROS causes
upregulation of iron response and the hypersensitivity phenotype is only observed
during a condition under which the exonuclease mutant has higher ROS levels than
wild-type cells.
Since initially the reason for examining ROS sensitivity was the possibility of too
much iron causing increase in ROS, it seems counterintuitive that the opposite
would also be true and too much ROS would cause increase in iron response.
However, it should be considered that iron can exist in two different forms in the
cell – free iron or bound iron and this could make a difference in the way oxidative
stress and iron response could be related. Iron is rarely found in free form. It is
usually sequestered in the vacuole or it is bound as a part of a protein prosthetic
group. Too much free iron would cause oxidative stress and would be resulting in
lowering of iron import and activating vacuolar sequestration of iron. However, too
much oxidative stress also damages the bound iron, resulting in increased needs
for iron due to damage in iron-sulfur clusters (Imlay, 2003). Therefore simply looking
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at the fact that iron response is activated and having shown that it is related to
oxidative stress rather than misregulated, it can reasonably be suggested that it is
the bound iron that is affected and not that the cell has too much free iron. That
conclusion is supported by the fact that only the iron sulfur protein in the bc1
complex of the ETC was affected and it had a lower than wild-type level.
Additionally, no vacuolar genes related to iron storage were affected in the
exonuclease mutant, further supporting this hypothesis because the vacuole is the
site for iron storage in S. cerevisiae.
I have established that the increased ROS is related to the iron activation. The
next question that needs to be answered is what causes the increased ROS in the
rrp44-exo- mutant, if it is not activation of the ETC. A major possibility is that the
aberrant glucose metabolism itself causes the ROS generation. Since the rrp44exo- strain had less ethanol, and had lowered pH in the medium, it was concluded
that either lactic acid or acetic acid production maybe increased in this mutant. Both
lactic acid and acetic acid are known to induce oxidative stress in S. cerevisiae
(Abbott et al., 2009; Semchyshyn et al., 2011). Furthermore lactate is known to
react with ferric ion to form a complex which then, via the Fenton reaction, reacts
with H2O2 to enhance the OH production (Ali et al., 2000). Finally, a microarray
examining the role of acid stress on gene expression, found that iron response
genes, regulated by Aft1, were upregulated upon stress with either lactic acid or
acetic acid (Kawahata et al., 2006). Therefore it is possible that altered glucose
metabolism, resulting in higher production of either lactic or acetic acid, is the
reason for the increase of ROS and iron response in the rrp44-exo- strain.
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The pH of the medium, however, was lower even after the diauxic shift, yet ROS
production was at wild-type levels. An explanation of this phenomenon could be that
after the diauxic shift, enzymes that detoxify ROS are upregulated and lower the
ROS levels. In fact it has been shown that overexpression of catalase reduced
oxidative stress induced by lactic acid (Abbott et al., 2009).
It would be interesting if in fact all of the physiological responses examined in this
and the previous chapter stem from the aberrant fermentation that the rrp44-exocarries out. Further experiments to distinguish the exact type and ratio of
fermentative processes that are carried out will help further narrow down what
exactly is affected in the pathway, Regardless of the results, the fact that RNA
metabolism affects glucose metabolism is intriguing by itself and finding the exact
regulatory RNA will be very exciting.
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Chapter 7: Conclusions and perspective
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The RNA exosome is a major exoribonuclease in eukaryotes and archaea, which
also has endonuclease activity in eukaryotes. The work presented in this
dissertation examines some important aspects of the RNA metabolism by the
exosome. First, I have begun characterizing the cap proteins of the RNA exosome.
These proteins, Rrp4, Rrp40, and Csl4, because of their location at the entry site of
the substrate, are possibly important in stabilizing the substrate and/or providing
specificity to the exosome. Specificity may be provided either directly by binding to
particular RNAs or indirectly, by interacting with other exosome co-factors or RNA
bound proteins which in turn provide specificity. Second, I have examined the
physiological relevance of the exonuclease for cellular processes. Therefore, both
of these aspects of my research, the characterization of the structure/function
relationships of the proteins at the site of RNA entry and the physiological effect of
the exosome, will serve as important basis for future research into the role of the
exosome.

CONCLUSIONS AND FUTURE DIRECTIONS IN THE STUDY OF THE EXOSOME
CAP PROTEINS

Rrp4 and Rrp40 have a structural role in the exosome
Rrp4 and Rrp40 are essential proteins and, as presented in Chapter 3, all of their
three domains need to be expressed for viability. As similar as these two proteins
are structurally, I have shown that they each have unique functions that cannot be
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substituted by the other one. Additionally, chimeras of the two proteins do not
substitute for each other indicating that the precise location of the proteins, not only
their close proximity to the exosome entrance site, is important. Finally, in cis
expression of Rrp4 domains also does not substitute for the essential role of Rrp4.
All of these data strongly suggest that Rrp4 and Rrp40 have a structural role in the
assembly of the exosome complex. Interestingly, an in vitro study showed assembly
of the exosome with any two of the cap proteins, and also an exosome with only
Rrp40 (Malet et al., 2010). The Malet et al. study implies that only Rrp40 is
absolutely required for a stable assembly of the exosome which contradicts the data
shown in Chapter 3 that suggests that Rrp4 also has a role in bridging PH subunits.
However it is possible that if the exosome exists in more than one conformation,
Rrp4 may be needed for only one. Such a scenario may be missed by in vitro
studies, because confirmations may be driven be specific biochemical or genetic
factors that are not available in the context of the in vitro studies. In fact, such a
scenario may be missed also in the context of in vivo studies as they are usually
carried out under specific standard conditions that do not vary. As I have shown in
Chapter 6, the exonuclease mutant has different growth phenotype, ROS amount,
and iron response activation depending on the carbon source. These differences
were missed in traditional studies done with glucose and during logarithmic growth
phase. A comprehensive study, compiling data from various exosome studies, has
pointed out that published TAP-tagged purifications of the exosome differ in the
composition of the proteins that elute with one or another exosome subunit
suggesting that there may be different exosome complexes (Kiss et al., 2012). It is
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also known that at least in archaea, the exosome exists in different confirmations,
specifically of the cap proteins including homotrimers of either Rrp4 or Csl4, and
heterotrimer composed of both Rrp4 and Csl4 (Lorentzen et al., 2007; Roppelt et
al., 2010; Witharana et al., 2012). Therefore it is possible that a confirmation of the
exosome, driven by some other, unknown conditions, does in fact require Rrp4 for
its structural integrity.
In addition, at least for Rrp4, my data imply that it has a functional role outside of
the exosome complex. This role is currently unknown and I have suggested
experiments (see below) to address this proposed role. It is also possible that Rrp4
has a non-essential role, given the fact that it is post-translationally modified by
phosphorylation, but this phosphorylation is not required for viability. The most likely
possibility is that this phosphorylation has a regulatory role. To determine a possible
role for the phosphorylation, I have suggested a series of experiments designed to
comprehensively look at the effects of the potential regulation by the
phosphorylation.

Csl4 does not stabilize the exosome by bridging PH ring proteins
Unlike Rrp4 and Rrp40, I have determined that the third cap protein Csl4 does not
have role in bridging subunits of the PH ring of the exosome, thus it follows that it
has only a functional role. Therefore the essential role of Csl4 may be to bind RNA
or protein cofactors. At this time either of these possibilities is likely.
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Whether the proposed RNA or protein binding takes place initially at the entrance
site of the exosome central channel is debatable. Based on the research I have
presented in this work, I cannot currently rule out that RNA or proteins are bound by
Csl4 away from the exosome complex. The fact that viable Csl4 truncations lose
most of their interactions with the exosome suggests that stable interactions are not
required for viability. Further experiments need to address this possibility by
repeating the experiment in a strain in which CSL4 is deleted and the truncations
are the only Csl4 available in these cells, as described in the conclusion section of
Chapter 4.
Following are several experimental approaches that will help answer important
questions regarding the cap proteins of the exosome. First, what are the roles of the
individual domains of the cap proteins? Second, what are the functions of the cap
proteins? Third, what, if any, are the roles of the cap proteins exclusive of the
exosome complex? And finally, what are the roles of the phosphorylation of Rrp4
and Csl4?

Future directions: Determining the roles of individual domains of the cap
proteins
To determine the role of specific domain interactions, the TAP tagged truncations
of the individual Rrp4, Rrp40, and Csl4 protein can be used. Briefly, plasmids with
truncations and full length Rrp4, Rrp40, and Csl4 sequences would be transformed
individually into a wild-type S. cerevisiae strain. After growth to log phase cells will
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be harvested, and total protein will be isolated. The total proteins will be run through
a IgG sepharose column to pull-down the TAP-tagged protein along with any protein
binding partners. The bound fraction will then be analyzed by mass spectroscopy to
identify all the binding partners. Comparing of the mass spectroscopy data of the
binding partners of the full-length protein and the truncation will indicate which
proteins (if any) are missing from the fractions bound to truncations. To determine if
a domain does in fact interact with a given protein, the individual domain and its
proposed protein binding partner should be expressed and purified from E. coli and
in vitro binding assay should be carried out to confirm that the proposed interaction
is only with that domain and it is direct. In addition to the technical challenges, one
caveat of this experiment is that if the role of a domain is to bind RNA, this will be
missed because this approach only tests for protein-protein interaction. If no change
in protein-protein interaction is discovered, a possibility that this particular domain
binds RNA should be considered. However, a role of a domain may be to both
interact with proteins and RNA at different surfaces, therefore the interpretation of
the results should be carefully done, to avoid overreaching conclusions should a
binding partner for a domain is discovered. To avoid such errors, an assay for RNA
binding can also be done. Since the cap proteins are believed to bind RNA nonspecifically, the use of complicated assays such as RIP-seq (RNA
immunoprecipitation followed by high-throughput sequencing) may not be warranted
as the amount of data from these high throughput assays may be overwhelming to
allow for straightforward interpretation. In-vitro assays for exosome activity have
been done with generic RNA substrates, thus such substrates can be used in gel-
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shift assays together with the various Rrp4, Rrp40, and Csl4 truncations. Thus,
both of these experiments, the truncation pull-down and the RNA binding assay
should add to the characterization of the roles of the individual domains of the cap
proteins. One exception will be the RPL27-like domain and the S1 domains of
Rrp40. For these two domains individual distinction will not be possible using this
method as they are not expressed individually, but a point mutagenesis approach
may be more suitable.

Future directions: Determining the functions of the cap proteins
I have shown that the cap proteins have a functional role. However what that
functional role is not clear. It is possible that the functional role is the same as for
the exosome complex, or there is a possibility that individual proteins contribute to
different functional roles. To determine the functional role of the cap proteins,
microarray analyses with poly(A) RNA can be completed. Because each of these
proteins is an essential protein, they cannot be deleted. However they can be at
least temporary depleted. One widely used method, and one that has also been
used with the exosome proteins is depletion by the use of the GAL promoter
(Allmang et al., 1999a). However, in Chapter 6 of this dissertation I have shown that
glucose metabolism is affected in the exosome mutant. I have not specifically
examined growth on galactose, but given the aberrancies seen when glucose is
used as a carbon source, it is my opinion that a sugar regulated promoter should be
avoided when completing experiments involving the exosome. The best option
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would be to use a promoter, such as tetracycline regulatable promoters that are
independent of sugar type and availability and are also commercially available (Gari
et al., 1997).
To look at the role of the cap proteins the Tet-off system can be used with the
wild-type TAP-tagged sequence of Rrp4, Rrp40, or Csl4 and transformed into the
corresponding deletion strain. The depletion, after tetracycline addition, will be
monitored by a Western blot with antibody against the TAP tag and simultaneously
cells would be harvested, and total RNA will be extracted to be used for microarray
analysis.
Several conclusions can be drawn for such data, depending on the final results.
First, the microarray results of cap protein depletion may show completely
overlapping results with the microarray results of the rrp44-exo- presented in this
dissertation. Such results, even though unlikely, would suggest that both the cap
protein and Rrp44’s functional roles are as a part of the exosome complex. Second,
the microarray results of cap protein depletion may have some, but not all
overlapping results with the microarray results from the rrp44-exo- and not have
additional RNA changes. Such results will also suggest that the cap protein’s
functional role is as a part of the exosome complex, because a role outside of the
exosome complex would involve different, not overlapping substrates. Third, in
addition to overlapping results, the cap protein depletion microarray may present
additional changes in RNA not detected in the rrp44-exo- microarray, which would
suggest that the particular cap protein has a role outside of the exosome complex.
Fourth, because the exosome proteins are essential, depletion of one of them may
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lead to changes not directly associated with the exosome, but provoked by other
mechanisms related to the cell dying and this should be kept in mind while
investigating the results from the microarray.

Future directions: Determining the cap proteins roles outside of the exosome
complex
Several lines of evidence suggest that the cap proteins may have roles outside of
the exosome. First, cap proteins have been visualized in distinct cellular foci
(Graham et al., 2006). Second, I have shown in this dissertation that at least Rrp4 is
stable out of the exosome complex. This stability assay can be extended to Rrp40
as well. To examine possible roles outside of the exosome complex, point mutations
leading to dissociation with the exosome can be created by analyzing the interacting
surfaces between the cap protein and the exosome subunits of the PH ring. A
coimmunoprecipitation assay if the mutant proteins with the exosome should be
done to confirm that the mutants do not bind the exosome. To determine if the
essential role of the cap protein is outside of the exosome complex, plasmid shuffle
assay with the mutated cap protein can be used with a strain which has tetracyclineregulatable wild-type cap protein. This experiment will be suitable specifically for
Csl4, since Rrp40 is known to have a structural role, and my data suggest that Rrp4
also may have a structural role. If the essential role of Csl4 is out of the exosome
complex, upon depletion with tetracycline, there will be no effect on growth of this
mutant compared to a mutant in which wild-type Csl4 has been introduced.
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Alternatively, if the essential role of Csl4 is as a part of the exosome complex, then
upon depletion of the wild-type Csl4, the growth will slow down and the strain will
ultimately stop growing.
To look for non-essential roles of the cap proteins that are not as a part of the
exosome complex, TAP-tagged mutants that do not interact with the exosome, as
described above, can be introduced into wild-type strain of S. cerevisiae and pulldown assays can be completed followed by mass spectrometry analyses to look for
interacting proteins. The protein binding profile of these mutants can then be
compared to mass spectrometry profile of wild-type cap protein to determine which,
if any, protein interactions are specific to the mutant proteins.

Future directions: Determining the role of posttranslational modifications of
Rrp4 and Csl4
The presence of posttranslational modifications in Rrp4 and Csl4 suggest that
these two proteins are regulated. I have shown that such regulation is not related to
the essential function of these proteins, but nevertheless it would be interesting to
know why these proteins are posttranslationally modified. Posttranslational
modifications could be used by the cell to regulate protein localization, abundance,
or interactions with other proteins. To determine what is the role of the
phosphorylation of Rrp4 and Csl4, the phosphomutants of Rrp4 and Csl4 that I
created for this work (see Chapters 3 and 4) can be used in variety of assays. First,
to look for protein binding partners on a global scale, pull-down assays followed by
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mass spectrometry can be done with these mutants and compared to wild-type.
Second, to look for changes in gene expression, microarrays can be completed with
these mutants and compared to wild-type strains. Third, to look for changes in
abundance, the phosphomutant protein levels can be compared to wild-type
corresponding protein by Western blots. Forth, to look for localization changes, the
mutants can be tagged with GFP and their cellular localization can be observed by
florescent microscopy. Altogether, completing this set of experiments should
generate data which will determine the role of the posttranslational phosphorylation
of these two proteins.

CONCLUSIONS AND FUTURE DIRECTIONS IN THE STUDY OF THE
EXONUCLEASE FUNCTIONAL IMPORTANCE
The exonuclease is the primary activity of the exosome
The catalytic subunit of the Rrp44 has two RNase activities. First, it has an
exonuclease activity and second it has an endonuclease activity. Interestingly, using
a microarray analysis and an analysis of internally cut RNAs I have not been able to
identify any substrates for the endonuclease. Yet the endonuclease is able to
substitute for the essential role of Rrp44, even though a strain having only
endonuclease activity grows slower. In contrast, a strain having only exonuclease
activity does not have any apparent growth defect. Together with the data that
known substrates of the exosome are only affected in exonuclease mutant, this
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indicates that the exonuclease is the main activity of Rrp44. One explanation of the
lack of specific substrates coupled with the ability to provide viability would be that
the endonuclease’s role may be to provide supporting function to the exonuclease.
For example if the endonuclease cleaves substrates that have stronger secondary
structures to speed up their degradation, it may not have specific substrates unique
to it. Rather, in the absence of the exonuclease, the endonuclease would cleave all
essential substrates and if that slows down the process, may result in the slower
growth phenotype. Another possibility is that just for the essential substrates the
exosome has developed a second degradation site, to ensure that they are
processed and/or degraded.

Future directions: Determining the essential substrates of the exosome
The modest effect in gene expression was surprising given the wide range of
substrates of the exosome. One possibility is that many substrates are affected by
both activities and knocking only one out does not result in appreciable mRNA
changes. An experiment that can be carried out in order to determine the effect on
gene expression of Rrp44 is to attempt to complete a microarray analysis or highthroughput sequencing using a double mutant rrp44-exo- rrp44-endo-. Briefly, a
rrp44-exo- rrp44-endo- strain carrying a Tet-regulatable rrp44-exo- on a plasmid,
could be grown in liquid YPD medium at OD600=0.6 and then the expression from
the Tet Promoter will be shut off by addition of Tetracycline to the medium. This will
result in a complete knock-out of the ribonucleic activities of Rrp44. Such mutant is
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inviable and will stop growing eventually, however depletion will be possible. The
duration of the depletion will have to be empirically determined. Cells can then be
collected, RNA extracted and sent either for microarray hybridization or highthroughput sequencing. For a control a knockout of only the exonuclease can be
used. Any RNA the level of which is changed in the double mutant will be
considered to be resulting from overlapping functions of the exonuclease and the
endonuclease and will further be investigated. A possible difficulty of this
experiment is that the time during which both activities will be knocked-out may not
be sufficient to determine any appreciable changes especially in non-coding stable
RNAs. mRNAs half-life in S. cerevisiae vary greatly with 91% of the transcripts have
a half-life between 12 and 29 minutes (Munchel et al., 2011) but stable RNAs
persist throughout the life of the cell and appreciable depletion could be seen upon
cell division. Exosome mutants start accumulating defects in 7S rRNA and 5’ETS
8hrs after a Tetracycline shut off of the Tet-off promoter, and the experiment was
carried out for 22 hours (Dziembowski et al., 2007).
The results from the experiment with this double mutant will point to why the
exosome is essential because they will give the changes in gene expression. The
results from a deep sequencing experiment with this mutant will be more
complicated to interpret because the exosome affects may different RNAs.
However, the deep sequencing approach is more useful if the specific substrates of
the exosome are to be identified.
Another approach that can be taken to identify essential roles of the exosome is to
carry out a genetic complementation screen. A library of S. cerevisiae ORFs can be
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transformed into an rpp44-exo- rrp44-endo- mutant to screen for loss of synthetic
lethality. However this approach may only be effective if the synthetic lethality is due
to one or a few genes. If the synthetic lethality results from a global effect on gene
expression then this genetic test will not be useful.

Model of how rrp44-exo- affect physiological responses of the cell
In chapter 6 I showed that the rrp44-exo- mutant affects glucose metabolism and
that during glucose growth, rrp44-exo- outputs less ethanol than wild-type strain
while simultaneously acidifying the medium more than the wild-type strain. The slow
growth on glucose correlated with higher ROS production. Additionally I showed
that iron response was activated during oxidative stress and that addition of iron
improved the growth of an oxidatively stressed rrp44-exo- mutant. Based on
comprehensive analysis of the above data, I have developed a model of how rrp44exo- affects iron response in YPD medium (Figure 7-1). Knowing that lactic acid
causes oxidative stress, I postulate that the rrp44-exo- mutant produces more acid
(either lactic or acetic acid) during glucose metabolism, which in turn leads to the
production of increased amount of ROS and therefore to activation of iron response
(Figure 7-1). Both acetic and lactic acid induce oxidative stress in S. cerevisiae
(Abbott et al., 2009; Semchyshyn et al., 2011), therefore either one will be capable
of inducing such physiological response. Additionally, both acetic and lactic acid
induce iron response genes similarly to the ones induced in the rrp44-exo- mutant
(Kawahata et al., 2006).
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Future directions: Testing the model of how the rrp44-exo- mutant affects
physiological responses of the cell
There are several experiments that could be carried out in order to test my model.
First, there are two possibilities for the lower pH in the medium of rrp44-exo- : one is
increase in lactic acid; the other is increase in acetic acid. To be able to further
narrow down what element of glucose metabolism is affected in rrp44-exo- it is
necessary to determine which one of these acids causes the increased acidity of
the medium. Kits able to measure either one of these acids are commercially
available and can be used for that purpose. To test the possibility that acidification
causes the slow growth of rrp44-exo- an experiment to neutralize the acid in the
medium could be carried out. Buffering the medium has been shown to reverse the
growth impairments caused by lactic acid and acetic acid toxicity in S. cerevisiae
(Thomas et al., 2002). Wild-type and rrp44-exo- strains could be grown in YPD
medium which is monitored for pH change and the pH adjusted by KOH and HCl
addition as needed. Improvement in growth rate as compared to wild-type will
indicate that the slower growth phenotype is caused by the addition of acid.
Conversely, no change in growth phenotype will indicate that slower growth is
independent of acid production.
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Figure 7-1 A model of how rrp44-exo- affect physiological responses of the cell. Left Wild-type cells during growth with glucose as a carbon source grow preferentially by
ethanol fermentation, putting out in the medium mostly ethanol and some lactic and acetic
acid. Right – rrp44-exo- mutant during growth on glucose as a carbon source have lowered
output of ethanol and increased output of either lactic or acetic acid which leads to increase
ROS production which in turn leads to activation of the iron response.
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Lactic and acetic acid are known to cause an increase in oxidative stress. To test
if they are the specific cause for the oxidative stress production in rrp44-exo- ,wildtype and rrp44-exo- strains could be grown as their `medium is regularly exchanged
coupled with ROS measurement and northern blots to probe for iron response
mRNAs. In addition, medium form wild-type and rrp44-exo- mutant can be taken
and used to supplement a wild-type strain and to measure changes in growth rate,
ROS production and iron response mRNAs. In addition, an experiment in which
increasing amounts of lactic acid and/or acetic acid are added to the media could be
carried out to confirm increase of ROS and iron response activation. Results from
these experiments will identify if the source of the physiological responses seen in
rrp44-exo- is an excreted product in the medium from aberrant fermentation.

Final remarks
The RNA exosome in a major exoribonuclease involved in numerous cellular
processes. This dissertation contributes to the understanding of the importance of
this RNA degrading machinery by first characterizing the roles of the three cap
proteins in the exosome and second by beginning to elucidate the physiological
importance of the exonuclease of the exosome. Lastly, this work provides a testable
model to serve as a foundation for future experiments to elucidate the physiological
importance of the main catalytic activity of the RNA exosome.
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